US20090326076A1 - Foamable alcohol compositions, systems and methods of use - Google Patents

Foamable alcohol compositions, systems and methods of use Download PDF

Info

Publication number
US20090326076A1
US20090326076A1 US12/552,126 US55212609A US2009326076A1 US 20090326076 A1 US20090326076 A1 US 20090326076A1 US 55212609 A US55212609 A US 55212609A US 2009326076 A1 US2009326076 A1 US 2009326076A1
Authority
US
United States
Prior art keywords
foam
compositions
composition
dimethicone
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/552,126
Inventor
Robert A. Asmus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20090326076(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to US12/552,126 priority Critical patent/US20090326076A1/en
Publication of US20090326076A1 publication Critical patent/US20090326076A1/en
Priority to US12/878,786 priority patent/US20100331411A1/en
Priority to US12/878,793 priority patent/US20100327013A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/896Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/82Compounds containing silicon
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0094High foaming compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • C11D3/201Monohydric alcohols linear
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • C11D3/225Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin etherified, e.g. CMC
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • C11D3/3703Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3707Polyethers, e.g. polyalkyleneoxides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions

Definitions

  • the present invention relates to foamable alcohol compositions, systems for dispensing the compositions and methods for the use of the compositions.
  • Foamable soap products contain a significant quantity of air. While these compositions can be economically manufactured as compared with non-foamable compositions, the formulation of foamable compositions comprising a high alcohol content has generally required the compositions to be provided as aerosol products which include a propellant (e.g., hydrocarbon, fluorocarbon, compressed gas) to facilitate foaming when the composition is dispensed from an aerosol container.
  • a propellant e.g., hydrocarbon, fluorocarbon, compressed gas
  • aerosol compositions can also include polymeric gelling agents, moderately high molecular weight (e.g., C 16 to C 22 ) alcohols and nonionic surfactants, for example. Aerosol products are costly to manufacture because of the need for a pressurized container and the inclusion of a foaming propellant.
  • non-aerosol soap products having a high alcohol content surfactants have been included in such compositions to facilitate some level of foaming when the compositions are dispensed through a mechanical pump or the like.
  • Surfactants can facilitate at least some degree of initial foaming, but such non-aerosol foams are often unstable and tend to collapse as soon as they are dispensed.
  • fluorochemical surfactants While some fluorochemical surfactants have been known to facilitate more stable foams in non-aerosol compositions, fluorochemical surfactants may raise environmental concerns.
  • the present invention provides a composition, comprising:
  • (C) Builder the builder in an amount sufficient to provide stability or to improve the stability of a foam formed from the composition.
  • the invention provides a system comprising a container and the composition as described above, the composition contained within the container under pressure and a propellant present within the composition.
  • the invention provides a system comprising a dispenser comprising a reservoir and a hand pump; and the composition as described above contained within the reservoir.
  • the invention provides a skin sanitizer comprising the composition as described above.
  • the invention provides a pre-surgical hand scrub comprising the composition as described above.
  • the invention provides a method for sanitizing a surface, comprising applying a volume of the composition as described above to the surface, the composition being in the form of a stable foam.
  • Builder refers to a material that can be incorporated as a component in the compositions of the invention to aid in the creation of a stable foam when the composition is dispensed from an aerosol or a non-aerosol dispenser.
  • Compositions comprising a builder can produce lower foam densities (greater volume) as compared to the same volume of the composition in the absence of the builder.
  • “Emollient” as used herein refers broadly to materials which are capable of maintaining or improving the moisture level, compliance, or appearance of the skin.
  • “Foam” refers to a frothy mass of bubbles formed on or from a liquid (e.g., the compositions of the invention).
  • HLB means the “hydrophile-liphophile balance,” or the balance between the oil soluble and water soluble moieties in a surface active molecule or surfactant.
  • Polymer as used herein refers to a natural or synthetic molecule having repetitive units and a number average molecular weight of at least 20,000.
  • poly(propylene oxide) and “poly(ethylene oxide)” are intended to be synonymous with “polypropylene glycol” or “PPG” and “polyethylene glycol” or “PEG,” respectively.
  • Poly(propylene oxide) and poly(ethylene oxide) are also abbreviated herein as “PPO” and “PEO,” respectively.
  • solvent solvent system
  • hydroalcoholic solvent hydroalcoholic solvent
  • “Stable,” as used when referring to a foamed composition, refers to foam that maintains a measurable height for a period of time of at least about 5 seconds following creation of the foam (e.g., by shaking the composition or by dispensing the composition from an aerosol or non-aerosol dispenser at ambient temperature). The stability of a particular foam may further be expressed in terms of the height of the foam after a measured period of time (e.g., 6 mm after 1 minute). Foam height measurements are further discussed in the Examples.
  • the invention provides a foamable composition comprised of alcohol, surfactant and builder.
  • the compositions of the invention may be aqueous compositions.
  • Optional ingredients such as antimicrobials and/or emollients, for example, may be included to provide or enhance the properties of the compositions.
  • the compositions of the invention provide the benefits of a foam for the disinfection of skin by providing a composition with a sheer thinning viscosity that is better than that for gelled compositions and which can be more easily rubbed onto sensitive tissue. Additionally, the compositions of the invention generally will dry quicker than a gel following application to a surface such as the hands, for example.
  • compositions of the invention will include at least one alcohol that provides the ability to rapidly kill a broad spectrum of microbes.
  • the compositions of the invention are suitable for use on the skin or other surfaces and may be used as a disinfectant for the hands, for example.
  • the alcohol or alcohols are monohydric alcohols.
  • the compositions of the invention comprise alcohols having lower hydrocarbon chain lengths such as C 2 to C 4 alcohols.
  • the compositions of the invention comprise a single alcohol. In other embodiments, a blend of two or more alcohols may be present.
  • the alcohol will consist of ethanol.
  • the alcohol will consist of propanol (e.g., n-propanol and/or isopropanol). In still other embodiments, the alcohol will consist of butanol (e.g., n-butanol, sec-butanol and tert-butanol). In some embodiments the alcohol is dissolved in water to provide an alcohol-water solvent.
  • Embodiments of the invention may comprise compositions having an alcohol content between about 35% and about 99.5% by weight.
  • the compositions of the invention will have an alcohol content within the range from about 60% to about 80%.
  • Compositions having an alcohol content within the foregoing ranges typically provide an efficacious bacterial kill.
  • At least one surfactant is present in the compositions of the invention.
  • surfactant may be present in the compositions of the invention at concentration ranges from about 0.1% to about 10% by weight, based on the total weight of the composition.
  • the surfactant may be present in a composition at a concentration ranging from about 0.5% to about 5% by weight, based on the total weight of the composition.
  • certain surfactants may impart a tacky or even a greasy feel to a composition when the surfactant concentration is greater than 5% by weight.
  • compositions of the invention are formulated with non-fluorinated surfactants and without the need for fluorochemical propellants.
  • dimethicone surfactants include dimethicone surfactants.
  • dimethicone surfactants include dimethicone copolyols—a polymer of dimethylsiloxane with polyoxyethylene (PEO) and/or polyoxypropylene (PPO) side chains.
  • these surfactants can be hydroxyl, methoxy or butoxy terminated, and the molar ratio of PEO to PPO (PEO/PPO) can range from 0/50 to 50/0 and the molecular weight of the dimethicone portion can range from 200 to 20,000.
  • the surfactants used in the invention can comprise specific dimethicone surfactants.
  • Specific surfactants suitable for use in embodiments of the invention include, without limitation, methoxy-terminated polyethylene glycol dimethicone having an average molecular weight of about 3000; dimethicone with a pendant ether of 35/65 (w/w) polyethylene glycol/polypropylene glycol copolymer having a combined average molecular weight of about 7,000; dimethicone copolyol with 18/18 (molar ratio) polyethylene glycol/polypropylene glycol; a dimethicone copolyol with 17/18 (molar ratio) polyethylene glycol/polypropylene glycol; a dimethicone copolyol with polyethylene glycol/polypropylene glycol-methoxy terminated having an average molecular weight of about 20,000 and a HLB of 9-12; dimethicone copolyol with a methoxy-terminated polyethylene glycol having a combined average molecular weight of about 3000; dimethicone copo
  • the following surfactants may be useful in the invention: dimethicone bisamino hydroxypropyl copolyol, dimethicone copolyol acetate, dimethicone copolyol adipate, dimethocone copolyol almondate, dimethicone copolyolamine, dimethicone copolyol avocadoate, dimethicone copolyol beeswax, dimethicone copolyol behenate, dimethicone copolyol benzoate, dimethicone copolyol bishydroxy ethylamine, dimethicone copolyol borageate, dimethicone copolyol butyl ether, dimethicone copolyol cocoa butterate, dimethicone copolyol crosspolymer, dimethicone copolyol dhupa butterate, dimethicone copolyol eth
  • At least one builder may be included in the compositions of the invention in order to stabilize the foams produced from the compositions when the compositions are shaken, or when they are dispensed from either an aerosol or a non-aerosol dispenser.
  • the inclusion of certain builders can provide cosmetic attributes to the compositions of the invention. Suitable builders can include one or more of the following: poly(ethylene oxide), hydroxyethyl cellulose, hydroxypropyl cellulose.
  • the builder will comprise only one of the foregoing. In other embodiments, the builder will comprise a combination of two or more of the foregoing builder.
  • the builder will comprise a poly(ethylene oxide) having an average molecular weight in the range from about 200,000 to about 4,000,000.
  • a poly(ethylene oxide) suitable for use in the compositions of the invention is that know under the designation POLYOXTM and commercially available from Dow Chemical Canada Inc., Sarnia, Ontario.
  • Suitable POLYOX compositions include those designated as “WSR N12K” having an average molecular weight of 1,000,000; “WSR-301” having an average molecular weight of 4,000,000; “WSR N60K” having an average molecular weight of 2,000,000; and “WSR N-80” having an average molecular weight of 200,000.
  • the builder when included in the compositions of the invention, may be present at a concentration between about 0.001% and about 5% by weight. In some embodiments, the builder may be present at concentrations less than or equal to about 0.1%. In some embodiments, the builder is present in the composition at concentrations of about 0.06%.
  • the builder enhances the stability of the foam produced when the composition of the invention is shaken or when the composition is dispensed.
  • Builders suitable for use in the invention will include those that provide or enhance the stability of the foam—i.e., those that provide a measurable foam height over at least about 5 seconds following the creation of the foam.
  • the builder is soluble in the alcohol that is used in the compositions of the invention.
  • the builder will be swellable within the alcohol.
  • the builder can be characterized as dispersible in the alcohol.
  • suitable foam builders include compounds comprising high molecular weight polymers.
  • these polymers are alcohol or hydroalcoholic soluble.
  • Specific polymers useful in the invention include, without limitation: Poly(ethylene oxide) (molecular wt of 100,000 to 10,000,000), high molecular weight polyethylene-polypropylene copolymers, hydroxyethyl cellulose, hydroxypropyl cellulose. When present, the polymer will be at a concentration of between about 0.001 and about 5%. In some embodiments, the polymer concentration will be between about 0.01% and about 0.5%.
  • Polymers within the following classes can be useful as builders in the compositions of the invention: hydroxypropyl guar, polyquaternium-4, polyquaternium-10, cetyl hydroxyethylcellulose, ethylhydroxy ethyl cellulose, polyglycerol, high molecular wt. polyoxamer, high molecular wt.
  • polyoxamine polyacrylamide, high molecular wt polyethylene glycol esters and ethers with alkyl alcohols or acid functional alkyls, polyacrylamidomethylpropane sulfonic acid, polyacrylic acid, polyethylene/isopropyl maleate/malaic acid copolyol, polymethacrylamidopropyltrimonium chloride, polymethacrylamidopropyltrimonium methosulfate, polymethacrylic acid, polyquaternium-1 to polyquaternium-47, polyvinyl methyl ether, butylated poly vinyl pyrrolidone, hydroxypropyl methylcellulose; hydroxypropyl cellulose; crosslinked and noncrosslinked homopolymer or crosslinked and noncrosslinked copolymer containing n-vinyl lactam monomeric units.
  • Non-limiting examples of N-vinyl lactam monomers are N-vinyl-2-pyrrolidone; N-vinyl-2-valerolactam; N-vinyl-2-caprolactam; and mixtures of any of the foregoing.
  • the poly(N-vinyl lactam) is a homopolymer of N-vinyl-2-pyrrolidone.
  • Nonlimiting examples of comonomers useful with the aforementioned N-vinyl lactam monomers include N,N-dimethylacrylamide, acrylic acid, methacrylic acid, hydroxyethylmethacrylate, acrylamide, 2-acrylamido-2-methyl-1-propane sulfonic acid or its salt, and vinyl acetate.
  • compositions of the invention will typically be of very low viscosities at 23° C.
  • the compositions of the invention can have different viscosities depending on the state of the composition.
  • a composition in a pre-dispensed condition i.e., it is in a “pre-foamed” state in a dispenser prior to being dispensed, can have a viscosity within the range from about 0.5 to about 100 cps at 23° C.
  • the prefoam viscosities of compositions of the invention will range from about 0.5 cps to about 50 cps.
  • the prefoam viscosities of compositions of the invention will range from about 0.5 cps to about 20 cps.
  • the composition will foam, and the foam will typically be of a higher viscosity than the viscosity of the liquid “non-foamed” composition prior to dispensing.
  • an emollient and/or other optional ingredients can also have an affect on viscosity (either positively or negatively).
  • compositions of the invention will foam when shaken of dispensed from a dispenser.
  • foam densities of the compositions can vary depending on any of a variety of factors.
  • the viscosity of the unfoamed composition discussed above, can have an effect on foam density.
  • the design of the dispenser or the non-aerosol pump used to deliver the foamed composition can have an effect on the foam density of the composition to the extent that the dispenser and/or the pump effect the foaming of the composition.
  • the amount of force applied to the pump and the relative speed at which the pump is operated when dispensing the composition can also have an effect on the foaming of the composition and its resulting viscosity.
  • compositions of the present invention may optionally include other ingredients such as salts, emollients, stabilizers, antimicrobials, fragrances, therapeutic agents, propellants and additional emulsifiers.
  • additional emulsifiers such as sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium tartrate, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite
  • Emollients can optionally be added to the compositions of the invention so that the compositions can be provided in a form that is capable of increasing the moisture content of the stratum corneum when the composition is applied to a user's hands, for example.
  • Emollients are generally separated into two broad classes based on their function. The first class of emollients function by forming an occlusive barrier to prevent water evaporation from the stratum corneum. The second class of emollients penetrate into the stratum corneum and physically bind water to prevent evaporation. The first class of emollients is subdivided into compounds which are waxes at room temperature and compounds which are liquid oils. The second class of emollients includes those which are water soluble and are often referred to as humectants.
  • the alcohol-water, surfactant and builder components used in the compositions of the invention are separate and distinct from components identified as emollients and optionally added to the composition.
  • Emollients may be added to the compositions in addition to the aforementioned silicone block surfactants and builder compounds which may also aid in maintaining or improving the skin condition of the user.
  • added emollients may be included the compositions of the invention at a concentration between about 0 and about 30% by weight.
  • the added emollient can be present in the composition at a concentration between about 0.5% and about 20%.
  • the emollient concentration can be between about 1% and about 12% by weight.
  • Suitable emollients may be selected from any of the classes known in the art.
  • a general list of useful emollients appears, for example, in U.S. Pat. No. 4,478,853 and in EPO patent application 0 522 624A1 as well as in the CTFA Cosmetic Ingredient Handbook published by The Cosmetic, Toiletry, and Fragrance Association, Wash. D.C. (1992) under the listings “Skin Conditioning agents,” “emollients,” “humectants,” “miscellaneous” and “occlusive.”
  • suitable emollients may be chosen from the following nonlimiting list of general emollients, occlusive emollients and humectants.
  • general emollients include short chain alkyl or aryl esters (C 1 -C 6 ) of long chain straight or branched chain alkyl or alkenyl alcohols or acids (C 8 -C 32 ) and their polyethoxylated derivatives; short chain alkyl or aryl ester (C 1 -C 6 ) of C 4 -C 12 diacids or diols optionally substituted in available positions by —OH; alkyl or aryl C 1 -C 10 esters of glycerol, pentaerythritol, ethylene glycol, propylene glycol, as well as polyethoxylated derivatives of these and polyethylene glycol; C 12 -C 22 alkyl esters or ethers of polypropylene; C 12 -C
  • occlusive emollients include cyclic and linear dimethicones; polydialkylsiloxanes; polyaryialkylsiloxanes; long chain (C 8 -C 36 ) alkyl and alkenyl esters of long straight or branched chain alkyl or alkenyl alcohols or acids; long chain (C 8 -C 36 ) alkyl and alkenyl amides of long straight or branched chain (C 8 -C 36 ) alkyl or alkenyl amines or acids; hydrocarbons including straight and branched chain alkanes and alkenes such as squalene, squalane and mineral oil; jojoba oil; polysiloxane polyalkylene copolymers; short chain alkyl or aryl esters (C 1 -C 36 ) of C 12 -C 22 diacids or diols optionally substituted in available positions by OH such as diisopropyl dimer d
  • Non-limiting examples of preferred humectant type emollients include glycerol, polyglycerols (including: diglycerol, triglycerol, polyglycerin-3, tetraglycerol, hexaglycerol, decaglycerols) propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol (PEG-2 to PEG-45M, preferably a molecular weight between about 300 and 1,000), sorbitol, polyhydric alcohol ethoxylates (e.g.
  • sorbeth-6 sorbeth-30, glycereth-1 to glycereth-31) methoxides of polyethylene glycol (Methoxy PEG-2 to Methoxy PEG-100) methoxides of polyhydric alcohol ethoxylates (e.g. glycereth-7 methoxide), pantothenol, gluconic acid salts and the like.
  • humectant-type agents like that could also be employed include: 1,2,6-hexanetriol, acetamide mea, aluminum hydroxide, arginine pea, butoxypropanol, butylene glycol, dimethyl imidazolidinone, dimethylsilanol hyaluronate, dipotassium glycyrrhizate, erythritol, ethoxy-diglycol, fructose, glucamine, gluconic acid, glucose, glucose glutamate, glucuronic acid, glutamic acid, glycogen, glycyrrhizic acid, heilmoor clay, hexacosyl glycol, histidine, hyaluronic acid, hydrogenated honey, hydrogenated starch, hydrolysate, hydrolyzed collagen, hydrolyzed elastin, hydrolyzed glycosaminoglycans, hydrolyzed keratin, hydrolyzed silk, hydrolyzed soy protein
  • emollients may affect the viscosity and stability of the compositions of the present invention.
  • a single emollient may be added to the composition.
  • two or more emollients may be added to the composition. While any of a variety of emollients may be added to the formulations of the present invention, some embodiments will include wax and oil type emollients either alone or combined with water soluble emollients.
  • emollient systems can be comprised of humectants in addition to occlusive wax and oil emollients in concentrations that achieve a moisturizing effect and which maintains and improves the condition of the skin upon repeated use.
  • Emollients may be non-comedogenic and chosen to avoid skin irritation or sensitization reactions.
  • one or more other antimicrobial agents may be added to enhance the antimicrobial properties of the compositions when they are used as pre-surgical hand scrubs or pre-surgical patient skin scrub replacements, for example.
  • the foamed composition of the present invention can deliver a secondary antimicrobial agent to the skin.
  • the secondary antimicrobial agent is added in levels up to 10% by weight of the total composition.
  • Non-limiting examples of suitable secondary antimicrobial agents include parachlorometaxylenol; triclosan; chlorhexidine and its salts such as chlorhexidine gluconate, poly hexamethylene biguanide and its salts such as poly hexamethylene biguanidine chloride, iodine, idodophors; fatty acid monoesters; poly-n-vinyl pyrrolidone-iodophors; silver oxide, silver and its salts, peroxides (e.g. hydrogen peroxide), antibiotics (e.g. neomycin, bacitracin, and polymixin B).
  • chlorhexidine and its salts such as chlorhexidine gluconate, poly hexamethylene biguanide and its salts such as poly hexamethylene biguanidine chloride, iodine, idodophors; fatty acid monoesters; poly-n-vinyl pyrrolidone-i
  • compositions of the invention can be used in the compositions of the invention to suppress the regrowth or possibly treat an infection of microorganisms, such as: 2,2-thiobis(4-chlorophenol); 4,4-isopropylidenediphenol; 5-amino-6-chloro-o-cresol; acetaminosalol; alcloxa; aldioxa; aluminum acetate; aluminum benzoate; aluminum diacetate; aluminum formate; aluminum phenolsulfonate; ammonium iodide; ammonium phenolsulfonate; benzisothiazolinone; benzotriazole; benzoxiquine; benzylparaben; berberine chloride; boric acid; cetethyl morpholinium ethosulfate; cetethyldimonium bromide; cetrimonium tosylate; cetylpyridinium chloride; chloramine-t; chlorothymol; cloflucarban; cocotrimonium
  • the following actives could also be of use to also reduce regrowth of microorganisms on skin: 2-bromo-2-nitropropane-1,3-dial; 4-hydroxybenzoic acid; 5-bromo-5-nitro-1,3-dioxane; 7-ethylbicyclooxazolidine; ammonium benzoate; ammonium bisulfite; ammonium propionate; ammonium sulfite; behentrimonium chloride; benzalkonium bromide; benzalkonium chloride; benzalkonium saccharinate; benzethonium chloride; benzoic acid; benzyl alcohol; benzylhemiformal; bromochlorophene; butyl benzoate; butylparaben; calcium benzoate; calcium paraben; calcium propionate; calcium salicylate; calcium sorbate; calcium undecylenate; cetalkonium chloride; cetearalkonium bromide; cetrimonium bromide; ce
  • the present invention further encompasses embodiments incorporating antimicrobials such as benzoyl peroxide so that the composition may be useful as an acne medication, for example.
  • the compositions of the present invention may also be formulated with barrier compounds to form barrier creams and lotions.
  • Materials which may be added to provide barrier protection for use as skin barriers to protect against diaper rash include but are not limited to 0.1 to 60% aldioxa, allantoin, aluminum acetate, aluminum hydroxide, bismuth subnitrate, boric acid, calamine, cellulose (microporous), cholecalciferol, cocoa butter, cod liver oil (in combination), colloidal oatmeal, cysteine hydrochloride, dexpanthenol, dimethicone, glycerin kaolin, lanolin (in combination), live yeast cell derivative, mineral oil, peruvian balsam, peruvian balsam oil, pertrolatum, protein hydrolysate (1-leucine, 1-isoleucine, 1-methionine, 1-phenylalanine, and 1-tyrosine), racemethionine, shark liver oil, sodium bicarbonate, sulfur, talc, tannic acid, topical starch, vitamin A, white petrolatum, zinc acetate, zinc carbonate and
  • compositions of the invention may comprise one or more formulations containing antifungal agents for the treatment of fungal infections of the skin such as athlete's foot and the like.
  • While some embodiments will include one additional secondary antimicrobial agent, other embodiments of the invention can include two or more additional secondary antimicrobials. While the foregoing secondary antimicrobials can be added to the compositions individually or singly, combinations of two or more of the foregoing secondary antimicrobials are also contemplated within the scope of the invention.
  • compositions of the present invention may be formulated into non-aerosol products that can be dispensed from a reservoir using a hand-pump, for example, to dispense an amount of the composition whenever the hand pump is actuated.
  • the amount of the composition dispensed by the pump may or may not be metered so that the amount of composition dispensed may or may not be consistent.
  • the compositions of the invention are not limited to being dispensed from only one type of dispenser or through only one type of hand pump.
  • the compositions are capable of being formulated into an aerosol foam or a mousse by addition of propellant to the composition.
  • propellants can be chosen from chlorofluorocarbons (CFCs), hydrochlorofluorocarbons (HCFCs), hydrofluorocarbons (HFCs), perfluorinated alkanes, and lower alkanes (C1-C5) as well as nitrous oxide dimethyl ether and other solvent-soluble propellants.
  • Suitable lower alkanes include propane, butane, and isobutane, for example.
  • the propellant can comprise a 70/30 mixture of propane/isobutane.
  • composition In order to produce an aerosol composition the composition is first formulated and charged into an appropriate pressure rated container. A suitable propellant may then be added to the composition under pressure at approximately 2-30% preferably 3-20% by volume. The propellant may form a separate layer on the composition or the propellant may be emulsified or miscible in the composition.
  • compositions of the invention can be used in any of a variety of applications including use as a sanitizer for application to a surface.
  • the compositions of the invention are suitable for use on mammalian skin including the human hands.
  • the compositions may be used as a pre-surgical hand scrub.
  • non-aerosol formulations of the invention the compositions may be contained in a non-aerosol dispenser equipped with a conventional hand pump, and the composition may be pumped onto the hands or other areas of the body. The pumping action required to dispense the compositions will create a discrete volume of a dispensed composition in the form of a stable foam.
  • the aerosol formulation may be dispensed from a pressurized container in a discrete volume of foamed composition. After dispensing, the foam may be spread upon the surface of the skin to sanitize the skin, the hands or the like. While some residue may remain on the skin following evaporation of the alcohol component, the residue can comprise emollients or the like to provide a desired cosmetic effect. Consequently, the compositions of the invention provide a means for sanitizing skin in the form of a foamable composition which does not need to be rinsed from the skin following application of the foam to the area in need of sanitization. Alternatively, undesired residue remaining on the surface can be rinsed off with water, for example.
  • the present invention also encompasses systems for dispensing the compositions comprising a reservoir and an amount of composition retained therein, and means for dispensing the composition from the reservoir.
  • compositions of the present invention may be prepared by a variety of techniques and the ingredients may be added to one another in any order of addition. To ensure a composition of maximum stability, the components may be subjected to high shear (e.g. homogenized) for a limited time period.
  • high shear e.g. homogenized
  • compositions in the Examples were prepared in 60 gram samples by combining all components in a glass jar and rolling the jar overnight, on a mechanical roller.
  • the foam builder was introduced to the mixture by first preparing a premix of the foam builder at ranges from 0.5% to 8.0% wt/wt, prepared in water/alcohol. The appropriate weight of premix was then added to the mixture containing the other components prior to the step of mixing by rolling overnight.
  • the surfactants are known to contain significant quantities of PEO/PPO block copolymers of the type described herein as builders. These copolymers may be byproducts of the manufacturing process for the copolyol surfactants.
  • the surfactants and builders used in the compositions of the Examples are listed in Tables 1 and 2.
  • Dow 190 surfactant includes poly(ethylene oxide, propylene oxide) monoallyl ether acetate and polyether polyol acetate.
  • Dow 193 surfactant includes polyethylene oxide monoallyl ether.
  • Q2-5220 Resin Modifier includes poly(ethylene oxide, propylene oxide) monoallyl ether acetate; polyethylene glycol monoallyl ether acetate; and polyether polyol acetate.
  • Foam Pump A foam pump nozzle was used to generate foam from each composition.
  • the pump used was a pump dispenser, product Code F2, type F2-L11 255/150, available from Airspray International Inc. of North Pompano Beach, Fla.
  • Foam Collection vial Vials were used to collect foam from the pump dispenser while the foam height was being measured.
  • the vials were made of glass and were of either 40 or 80 mm height having a 25 mm internal diameter and a 27 mm outer diameter.
  • the Foam Pump was used to assess the foam forming property of the compositions.
  • the pump was rinsed between samples with deionized water by pumping water through the pump until it came out clear.
  • the pump dip tube was removed from the water and then pumped dry of residual water and then placed in the composition to be tested.
  • the pump was then pumped 3 times to prime the pump and then 3 more times to purge solution through the nozzle to ensure the system was ready.
  • three pumps worth of foam were collected in a collection vial by pumping slowly at a speed of about 1 second for each pump.
  • the vial containing the foam was placed on a flat surface, a timer was started and a small ruler with millimeter increments was used to measure the approximate height of the foam, ignoring the height of any remaining unfoamed composition.
  • the time to measure the foam height usually took about 5 seconds. Any composition producing a foam which was not stable at least 5 seconds was considered unstable and rated 0 mm.
  • the foam height was estimated to be the average height of the foam. A rating of 0 mm was given if the top of the solution was void of foam in any spot, usually the center. The foam height was recorded after 1, 3 and 5 minutes to determine the long term stability of the foam.
  • the percentage of foam volume increase over the solution volume was calculated by measuring the foam height in millimeters, subtracting 5 mm from the foam height and dividing the result by 5 (the volume of the un-foamed pumped solution) and multiplying by 100%.
  • Foam volume % increase measurements were made immediately following creation of the foam (e.g., after dispensing). Due to the difficulty in determining the exact foam surface, foam heights between 0-5 mm were reported as having a zero percent increase in foam volume.
  • Viscosity in centipoise was measured at 23° C. at ambient pressure using a Brookfield viscometer Model LVT equipped with a Brookfield LV spindle # 1 @ 60 rpm. All samples were allowed to equilibrate at 23° C. for 24 hours prior to measurement. The viscosity was taken at the lowest speed possible while staying within 10-100% of the viscometer range and more preferably between 20-80% of the range. The viscosity was read after one minute of testing. In all cases the sample size and container geometry was chosen to ensure that there were no wall effects. By “wall effects” it is meant the viscosity value is not affected by the container and is essentially equivalent to the viscosity taken in an infinitely large container. For this reason lower viscosity samples required a larger sample size to accommodate the larger spindles.
  • Examples 1-13 were prepared using various amounts of the surfactant Dow 190; plus a poly(ethylene oxide) (PEO) foam builder, available from Dow Chemical Company of Midland, Mich., under the trade name POLYOXTM WSR N12K; distilled water, and an alcohol solvent. Foam height measurements according to the above test method were taken for each sample. The foam height measurements and formulations for each of the Examples are set forth in Table 3.
  • PEO poly(ethylene oxide)
  • Examples 14-32 were all prepared with the same alcohol solvent, foam builder, surfactant and water content. The only variation in Examples 14-32 was the type of surfactant used.
  • the alcohol solvent was SDA-3-C and was present at 64.00%; the foam builder was PEO N12K (listed above) and was present at 0.06%; the water content was 25.50% and the amount of surfactant was 2.50%.
  • Foam height data and foam volume % increased data are reported in Table 4 for each of the compositions.
  • Examples 33-53 were all prepared with the same alcohol content of 65.00% USP 200 proof ethanol.
  • the amounts and type of surfactant, the amount of foam builder and the water content were varied. Comparative Examples C1-C4 had no surfactant. Examples C5 and C6 had no builder. Formulations, initial foam height measurements and foam volume % increases are reported in Table 5.
  • Examples 54-64 were all prepared with the same alcohol content of 65.00% USP 200 proof ethanol and the same surfactant content of 1.00% Q2-5220 Resin Modifier. The amounts and the type of foam builder were varied as was the water content. Composition, foam height and foam volume % increase are reported in Table 6.
  • Examples 65-73 were all prepared with the same surfactant content of 1.00%, Dow 190.
  • the amounts of foam builder, water content and USP 200 proof ethanol were all varied. Additionally the type of foam builder was also varied. Composition, foam height and foam volume % increase are reported in Table 7.
  • Examples 74-78 were formulated using PEO builders of different molecular weights. Dow 190 in an amount of 1.00% was used as the surfactant for all of the Examples 68-72. Formulation information and foam height data are given in Table 7. Fluid at an amount of 1.00%.
  • Table 9 list various additional (secondary to alcohol) antimicrobials that were added to the formulations described in Examples 73-76.
  • Examples 79-82 were formulated with the same components except that different secondary antimicrobials were used, as shown in Table 10. Foam height and foam volume % increase data are also set forth in Table 10.
  • Examples 83-107 were prepared to have the same alcohol content of 69.00% of USP 190 proof ethanol.
  • the Dow 190 surfactant and WSR-301 foam builder were used in various amounts as described in Table 11. Additionally, one or more emollient was added to each of the formulations. Formulations, initial foam height measurements and foam volume % increase are reported in Table 11.
  • Example 108-113 were prepared with the same alcohol content of 63.77% SDA-3-C; the same amount of surfactant, Dow 190 at 1.00% and the same foam builder PEO, N12K, at an amount of 0.060%, The type and amount emollient was varied, as was the amount of water. Initial foam height measurements and foam volume % increase were taken and are reported in Table 12.
  • Comparative Examples C7 and C8 were tested for initial foam height after being prepared using the materials of Table 13 in the amounts listed in Tables 14A and 14B.
  • Comparative Examples C9, C10 and C11 were prepared using the materials listed in Table 13 in the amounts listed in Table 15 and were tested using the standard Foam Height procedure described above.
  • Comparative Examples C12, C13 and C14 were prepared using various materials of Table 13 in the amounts listed in Table 16 and were tested using the standard Foam Height procedure described above.
  • Comparative Examples C15 and C16 were prepared using various materials of Table 13 in the amounts listed in Table 17 and were tested using the standard Foam Height procedure described above.

Abstract

A composition, systems for dispensing the composition and methods for the use of the composition are described. The composition comprises:
    • (A) Monohydric alcohol in an amount sufficient to provide antimicrobial activity;
    • (B) Surfactant comprising a dimethicone surfactant; and
    • (C) Builder, the builder in an amount sufficient to provide stability or to improve the stability of a foam formed from the composition.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 11/151,563, filed Jun. 13, 2005, which is incorporated herein by reference.
  • The present invention relates to foamable alcohol compositions, systems for dispensing the compositions and methods for the use of the compositions.
  • BACKGROUND
  • Foamable soap products contain a significant quantity of air. While these compositions can be economically manufactured as compared with non-foamable compositions, the formulation of foamable compositions comprising a high alcohol content has generally required the compositions to be provided as aerosol products which include a propellant (e.g., hydrocarbon, fluorocarbon, compressed gas) to facilitate foaming when the composition is dispensed from an aerosol container. These aerosol compositions can also include polymeric gelling agents, moderately high molecular weight (e.g., C16 to C22) alcohols and nonionic surfactants, for example. Aerosol products are costly to manufacture because of the need for a pressurized container and the inclusion of a foaming propellant.
  • In the formulation of non-aerosol soap products having a high alcohol content, surfactants have been included in such compositions to facilitate some level of foaming when the compositions are dispensed through a mechanical pump or the like. Surfactants can facilitate at least some degree of initial foaming, but such non-aerosol foams are often unstable and tend to collapse as soon as they are dispensed. While some fluorochemical surfactants have been known to facilitate more stable foams in non-aerosol compositions, fluorochemical surfactants may raise environmental concerns.
  • There is a need to provide foamable alcohol-containing compositions that are formulated to be anti-microbial and which can be applied to the skin (e.g., the hands). There is a need for alcohol-containing compositions that will form a stable foam in the absence of an aerosol propellant and which will deliver alcohol to the skin for rapid skin disinfection. Within the foregoing need, it is desirable to provide foamable, low viscosity, alcohol-containing compositions that are safe and efficacious while providing properties that may be desired by the consumer.
  • SUMMARY
  • In one aspect, the present invention provides a composition, comprising:
  • (A) Monohydric alcohol in an amount sufficient to provide antimicrobial activity;
  • (B) Surfactant comprising a dimethicone surfactant; and
  • (C) Builder, the builder in an amount sufficient to provide stability or to improve the stability of a foam formed from the composition.
  • In another aspect, the invention provides a system comprising a container and the composition as described above, the composition contained within the container under pressure and a propellant present within the composition.
  • In still another aspect, the invention provides a system comprising a dispenser comprising a reservoir and a hand pump; and the composition as described above contained within the reservoir.
  • In still another aspect, the invention provides a skin sanitizer comprising the composition as described above.
  • In still another aspect, the invention provides a pre-surgical hand scrub comprising the composition as described above.
  • In still another aspect, the invention provides a method for sanitizing a surface, comprising applying a volume of the composition as described above to the surface, the composition being in the form of a stable foam.
  • It will be appreciated that the terms used herein will be understood as being defined according to the understanding of those skilled in the art at the time of the present invention. However, certain terms used herein shall be understood as having the meaning that is expressly set forth herein:
  • “Builder” refers to a material that can be incorporated as a component in the compositions of the invention to aid in the creation of a stable foam when the composition is dispensed from an aerosol or a non-aerosol dispenser. Compositions comprising a builder can produce lower foam densities (greater volume) as compared to the same volume of the composition in the absence of the builder.
  • “Emollient” as used herein refers broadly to materials which are capable of maintaining or improving the moisture level, compliance, or appearance of the skin.
  • “Foam” refers to a frothy mass of bubbles formed on or from a liquid (e.g., the compositions of the invention).
  • “HLB” means the “hydrophile-liphophile balance,” or the balance between the oil soluble and water soluble moieties in a surface active molecule or surfactant.
  • “Polymer” as used herein refers to a natural or synthetic molecule having repetitive units and a number average molecular weight of at least 20,000.
  • As used herein, “poly(propylene oxide)” and “poly(ethylene oxide)” are intended to be synonymous with “polypropylene glycol” or “PPG” and “polyethylene glycol” or “PEG,” respectively. Poly(propylene oxide) and poly(ethylene oxide) are also abbreviated herein as “PPO” and “PEO,” respectively.
  • “Solvent”, “solvent system” or “hydroalcoholic solvent” as used herein refer to the alcohol and water combination in the present invention.
  • “Stable,” as used when referring to a foamed composition, refers to foam that maintains a measurable height for a period of time of at least about 5 seconds following creation of the foam (e.g., by shaking the composition or by dispensing the composition from an aerosol or non-aerosol dispenser at ambient temperature). The stability of a particular foam may further be expressed in terms of the height of the foam after a measured period of time (e.g., 6 mm after 1 minute). Foam height measurements are further discussed in the Examples.
  • Those skilled in the art will more fully understand the various features and aspect of the invention upon consideration of the remainder of the disclosure, including the Detailed Description, the Examples and the appended claims.
  • DETAILED DESCRIPTION
  • The invention provides a foamable composition comprised of alcohol, surfactant and builder. The compositions of the invention may be aqueous compositions. Optional ingredients such as antimicrobials and/or emollients, for example, may be included to provide or enhance the properties of the compositions. The compositions of the invention provide the benefits of a foam for the disinfection of skin by providing a composition with a sheer thinning viscosity that is better than that for gelled compositions and which can be more easily rubbed onto sensitive tissue. Additionally, the compositions of the invention generally will dry quicker than a gel following application to a surface such as the hands, for example.
  • Alcohol
  • The compositions of the invention will include at least one alcohol that provides the ability to rapidly kill a broad spectrum of microbes. The compositions of the invention are suitable for use on the skin or other surfaces and may be used as a disinfectant for the hands, for example. In embodiments of the invention, the alcohol or alcohols are monohydric alcohols. Typically, the compositions of the invention comprise alcohols having lower hydrocarbon chain lengths such as C2 to C4 alcohols. In some embodiments, the compositions of the invention comprise a single alcohol. In other embodiments, a blend of two or more alcohols may be present. In some embodiments, the alcohol will consist of ethanol. In still other embodiments, the alcohol will consist of propanol (e.g., n-propanol and/or isopropanol). In still other embodiments, the alcohol will consist of butanol (e.g., n-butanol, sec-butanol and tert-butanol). In some embodiments the alcohol is dissolved in water to provide an alcohol-water solvent.
  • Embodiments of the invention may comprise compositions having an alcohol content between about 35% and about 99.5% by weight. In some embodiments, the compositions of the invention will have an alcohol content within the range from about 60% to about 80%. Compositions having an alcohol content within the foregoing ranges typically provide an efficacious bacterial kill.
  • Surfactants
  • At least one surfactant is present in the compositions of the invention. In some embodiments, surfactant may be present in the compositions of the invention at concentration ranges from about 0.1% to about 10% by weight, based on the total weight of the composition. In some embodiments, the surfactant may be present in a composition at a concentration ranging from about 0.5% to about 5% by weight, based on the total weight of the composition. Those skilled in the art will appreciate that certain surfactants may impart a tacky or even a greasy feel to a composition when the surfactant concentration is greater than 5% by weight. While such surfactant concentrations are contemplated as within the scope of the invention, the skilled artisan may wish to consider the cosmetic effects of surfactant concentrations when formulating a composition for use by the consumer. In some embodiments, the compositions of the invention are formulated with non-fluorinated surfactants and without the need for fluorochemical propellants.
  • Specific surfactants useful in the invention include dimethicone surfactants. Examples of dimethicone surfactants include dimethicone copolyols—a polymer of dimethylsiloxane with polyoxyethylene (PEO) and/or polyoxypropylene (PPO) side chains. In some embodiments, these surfactants can be hydroxyl, methoxy or butoxy terminated, and the molar ratio of PEO to PPO (PEO/PPO) can range from 0/50 to 50/0 and the molecular weight of the dimethicone portion can range from 200 to 20,000. The surfactants used in the invention can comprise specific dimethicone surfactants. Specific surfactants suitable for use in embodiments of the invention include, without limitation, methoxy-terminated polyethylene glycol dimethicone having an average molecular weight of about 3000; dimethicone with a pendant ether of 35/65 (w/w) polyethylene glycol/polypropylene glycol copolymer having a combined average molecular weight of about 7,000; dimethicone copolyol with 18/18 (molar ratio) polyethylene glycol/polypropylene glycol; a dimethicone copolyol with 17/18 (molar ratio) polyethylene glycol/polypropylene glycol; a dimethicone copolyol with polyethylene glycol/polypropylene glycol-methoxy terminated having an average molecular weight of about 20,000 and a HLB of 9-12; dimethicone copolyol with a methoxy-terminated polyethylene glycol having a combined average molecular weight of about 3000; dimethicone copolyol with a methoxy-terminated polyethylene glycol having a combined average molecular weight of about 6000; dimethicone copolyol with a hydroxy terminated polyethylene glycol having a combined average molecular weight of about 5000 with an HLB of 13-17; dimethicone copolyol lactate; silicone copolyol pelargonate; hydroxyl-capped dimethicone copolyol; hydroxyl-terminated polyethylene glycol-12 dimethicone; dimethicone copolyol laurate; Silicone Quaternary 1; hydroxy-terminated polyethylene glycol dimethicone having an average molecular weight of about 4000; methoxy-terminated polyethylene glycol dimethicone having an average molecular weight of about 600; Silicone Quaternary 2 (Myristyl); sodium dimethicone copolyol acetyl methyltaurate; butoxy-terminated poly(propylene oxide) dimethicone having an average molecular weight of about 3,000; and silicone copolyol isostearate.
  • Additionally, the following surfactants may be useful in the invention: dimethicone bisamino hydroxypropyl copolyol, dimethicone copolyol acetate, dimethicone copolyol adipate, dimethocone copolyol almondate, dimethicone copolyolamine, dimethicone copolyol avocadoate, dimethicone copolyol beeswax, dimethicone copolyol behenate, dimethicone copolyol benzoate, dimethicone copolyol bishydroxy ethylamine, dimethicone copolyol borageate, dimethicone copolyol butyl ether, dimethicone copolyol cocoa butterate, dimethicone copolyol crosspolymer, dimethicone copolyol dhupa butterate, dimethicone copolyol ethyl ether, dimethicone copolyol hydroxy stearate, dimethicone copolyol isostearate, dimethicone copolyol kokum butterate, dimethicone copolyol lactate, dimethicone copolyol laurate, dimethicone copolyol mango butterate, dimethicone copolyol meadowfoamate, dimethicone copolyol methyl ether, dimethicone copolyol mohwa butterate, dimethicone copolyol octyldodecyl citrate, dimethicone copolyol olivate, dimethicone copolyol phosphate, dimethicone copolyol phthalate, dimethicone copolyol sal butterate, dimethicone copolyol shea butterate, dimethicone copolyol stearate, dimethicone copolyol undecylenate, dimethicone hydroxypropyl trimonium chloride, dimethicone propyl pg-betaine, polysilicone-10, polysilicone-8, dimethicone propylethylenediamine behenate, amino bispropyl dimethicone aminoethylaminopropyl dimethicone, behentrimonium dimethicone copolyol phthalate, bis-aminopropyl copolyol aminopropyl dimethicone, bis-hydroxyethoxypropyl dimethicone, cetyl triethylmonium dimethicone copolyol succinate, dimethicone copolyol sulfate, dimethicone copolyol phosphate, dimethicone polyglycerol, disodium copolyol dimethicone sulfosuccinate, copolyol polydimethylsiloxyethyl dimethicone, copolyol pg-coco-glucoside dimethicone, copolyol nonafluorohexyl dimethicone copolymer, copolyol methyl ether lauroxy peg amidopropyl dimethicone, copolyol oleyl ether dimethicone, sodium carboxydecyl copolyol dimethicone.
  • Combinations of two or more of the foregoing dimethicone surfactants in a single composition are also contemplated within the scope of the invention
  • Builder
  • At least one builder may be included in the compositions of the invention in order to stabilize the foams produced from the compositions when the compositions are shaken, or when they are dispensed from either an aerosol or a non-aerosol dispenser. In some embodiments, the inclusion of certain builders can provide cosmetic attributes to the compositions of the invention. Suitable builders can include one or more of the following: poly(ethylene oxide), hydroxyethyl cellulose, hydroxypropyl cellulose. In some embodiments, the builder will comprise only one of the foregoing. In other embodiments, the builder will comprise a combination of two or more of the foregoing builder. In some embodiments, the builder will comprise a poly(ethylene oxide) having an average molecular weight in the range from about 200,000 to about 4,000,000. One poly(ethylene oxide) suitable for use in the compositions of the invention is that know under the designation POLYOX™ and commercially available from Dow Chemical Canada Inc., Sarnia, Ontario. Suitable POLYOX compositions include those designated as “WSR N12K” having an average molecular weight of 1,000,000; “WSR-301” having an average molecular weight of 4,000,000; “WSR N60K” having an average molecular weight of 2,000,000; and “WSR N-80” having an average molecular weight of 200,000.
  • The builder, when included in the compositions of the invention, may be present at a concentration between about 0.001% and about 5% by weight. In some embodiments, the builder may be present at concentrations less than or equal to about 0.1%. In some embodiments, the builder is present in the composition at concentrations of about 0.06%.
  • In general, the builder enhances the stability of the foam produced when the composition of the invention is shaken or when the composition is dispensed. Builders suitable for use in the invention will include those that provide or enhance the stability of the foam—i.e., those that provide a measurable foam height over at least about 5 seconds following the creation of the foam. In some embodiments, the builder is soluble in the alcohol that is used in the compositions of the invention. In some embodiments, the builder will be swellable within the alcohol. In still other embodiments, the builder can be characterized as dispersible in the alcohol.
  • In some embodiments, suitable foam builders include compounds comprising high molecular weight polymers. In some embodiments, these polymers are alcohol or hydroalcoholic soluble. Specific polymers useful in the invention include, without limitation: Poly(ethylene oxide) (molecular wt of 100,000 to 10,000,000), high molecular weight polyethylene-polypropylene copolymers, hydroxyethyl cellulose, hydroxypropyl cellulose. When present, the polymer will be at a concentration of between about 0.001 and about 5%. In some embodiments, the polymer concentration will be between about 0.01% and about 0.5%.
  • Polymers within the following classes can be useful as builders in the compositions of the invention: hydroxypropyl guar, polyquaternium-4, polyquaternium-10, cetyl hydroxyethylcellulose, ethylhydroxy ethyl cellulose, polyglycerol, high molecular wt. polyoxamer, high molecular wt. polyoxamine, polyacrylamide, high molecular wt polyethylene glycol esters and ethers with alkyl alcohols or acid functional alkyls, polyacrylamidomethylpropane sulfonic acid, polyacrylic acid, polyethylene/isopropyl maleate/malaic acid copolyol, polymethacrylamidopropyltrimonium chloride, polymethacrylamidopropyltrimonium methosulfate, polymethacrylic acid, polyquaternium-1 to polyquaternium-47, polyvinyl methyl ether, butylated poly vinyl pyrrolidone, hydroxypropyl methylcellulose; hydroxypropyl cellulose; crosslinked and noncrosslinked homopolymer or crosslinked and noncrosslinked copolymer containing n-vinyl lactam monomeric units.
  • Non-limiting examples of N-vinyl lactam monomers are N-vinyl-2-pyrrolidone; N-vinyl-2-valerolactam; N-vinyl-2-caprolactam; and mixtures of any of the foregoing. Typically, the poly(N-vinyl lactam) is a homopolymer of N-vinyl-2-pyrrolidone. Nonlimiting examples of comonomers useful with the aforementioned N-vinyl lactam monomers include N,N-dimethylacrylamide, acrylic acid, methacrylic acid, hydroxyethylmethacrylate, acrylamide, 2-acrylamido-2-methyl-1-propane sulfonic acid or its salt, and vinyl acetate.
  • While the foregoing builders can be added to the compositions of the invention individually, combinations of two or more such builders are also contemplated within the scope of the invention as well as derivatives thereof.
  • Viscosity of Compositions
  • The compositions of the invention will typically be of very low viscosities at 23° C. In some embodiments, the compositions of the invention can have different viscosities depending on the state of the composition. For example, a composition in a pre-dispensed condition, i.e., it is in a “pre-foamed” state in a dispenser prior to being dispensed, can have a viscosity within the range from about 0.5 to about 100 cps at 23° C. In some embodiments, the prefoam viscosities of compositions of the invention will range from about 0.5 cps to about 50 cps. In still other embodiments, the prefoam viscosities of compositions of the invention will range from about 0.5 cps to about 20 cps. When a composition of the invention is dispensed from a non-aerosol pump-type dispenser, the composition will foam, and the foam will typically be of a higher viscosity than the viscosity of the liquid “non-foamed” composition prior to dispensing. It will also be appreciated that the addition of an emollient and/or other optional ingredients (discussed herein) can also have an affect on viscosity (either positively or negatively).
  • Foam Density
  • The compositions of the invention will foam when shaken of dispensed from a dispenser. It will be appreciated that the foam densities of the compositions can vary depending on any of a variety of factors. For example, the viscosity of the unfoamed composition, discussed above, can have an effect on foam density. Moreover, the design of the dispenser or the non-aerosol pump used to deliver the foamed composition can have an effect on the foam density of the composition to the extent that the dispenser and/or the pump effect the foaming of the composition. Additionally, the amount of force applied to the pump and the relative speed at which the pump is operated when dispensing the composition can also have an effect on the foaming of the composition and its resulting viscosity.
  • Optional Ingredients
  • In addition to alcohol-water, surfactant and builder, the compositions of the present invention may optionally include other ingredients such as salts, emollients, stabilizers, antimicrobials, fragrances, therapeutic agents, propellants and additional emulsifiers. Each of these optional ingredients along with the effect each has upon the properties of the final composition is discussed below.
  • Emollients can optionally be added to the compositions of the invention so that the compositions can be provided in a form that is capable of increasing the moisture content of the stratum corneum when the composition is applied to a user's hands, for example. Emollients are generally separated into two broad classes based on their function. The first class of emollients function by forming an occlusive barrier to prevent water evaporation from the stratum corneum. The second class of emollients penetrate into the stratum corneum and physically bind water to prevent evaporation. The first class of emollients is subdivided into compounds which are waxes at room temperature and compounds which are liquid oils. The second class of emollients includes those which are water soluble and are often referred to as humectants.
  • As referred to herein, the alcohol-water, surfactant and builder components used in the compositions of the invention are separate and distinct from components identified as emollients and optionally added to the composition. Emollients may be added to the compositions in addition to the aforementioned silicone block surfactants and builder compounds which may also aid in maintaining or improving the skin condition of the user. In some embodiments, added emollients may be included the compositions of the invention at a concentration between about 0 and about 30% by weight. In some embodiments, the added emollient can be present in the composition at a concentration between about 0.5% and about 20%. In still other embodiments, the emollient concentration can be between about 1% and about 12% by weight. Suitable emollients may be selected from any of the classes known in the art. A general list of useful emollients appears, for example, in U.S. Pat. No. 4,478,853 and in EPO patent application 0 522 624A1 as well as in the CTFA Cosmetic Ingredient Handbook published by The Cosmetic, Toiletry, and Fragrance Association, Wash. D.C. (1992) under the listings “Skin Conditioning agents,” “emollients,” “humectants,” “miscellaneous” and “occlusive.”
  • In some embodiments, suitable emollients may be chosen from the following nonlimiting list of general emollients, occlusive emollients and humectants. Examples of general emollients include short chain alkyl or aryl esters (C1-C6) of long chain straight or branched chain alkyl or alkenyl alcohols or acids (C8-C32) and their polyethoxylated derivatives; short chain alkyl or aryl ester (C1-C6) of C4-C12 diacids or diols optionally substituted in available positions by —OH; alkyl or aryl C1-C10 esters of glycerol, pentaerythritol, ethylene glycol, propylene glycol, as well as polyethoxylated derivatives of these and polyethylene glycol; C12-C22 alkyl esters or ethers of polypropylene; C12-C22 alkyl esters or ethers of polypropylene/polyethylene glycol copolymer.
  • Examples of occlusive emollients include cyclic and linear dimethicones; polydialkylsiloxanes; polyaryialkylsiloxanes; long chain (C8-C36) alkyl and alkenyl esters of long straight or branched chain alkyl or alkenyl alcohols or acids; long chain (C8-C36) alkyl and alkenyl amides of long straight or branched chain (C8-C36) alkyl or alkenyl amines or acids; hydrocarbons including straight and branched chain alkanes and alkenes such as squalene, squalane and mineral oil; jojoba oil; polysiloxane polyalkylene copolymers; short chain alkyl or aryl esters (C1-C36) of C12-C22 diacids or diols optionally substituted in available positions by OH such as diisopropyl dimer dilinoleate; and C12-C22 alkyl and alkenyl alcohols; long chain alkyl or aryl esters (C8-C36) of C12-C22 diacides or diols optionally substituted in available positions by —OH, such as diisostearyl dimer dilinoleate; lanolin and lanolin derivatives; and beeswax and its derivatives.
  • Non-limiting examples of preferred humectant type emollients include glycerol, polyglycerols (including: diglycerol, triglycerol, polyglycerin-3, tetraglycerol, hexaglycerol, decaglycerols) propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol (PEG-2 to PEG-45M, preferably a molecular weight between about 300 and 1,000), sorbitol, polyhydric alcohol ethoxylates (e.g. sorbeth-6, sorbeth-30, glycereth-1 to glycereth-31) methoxides of polyethylene glycol (Methoxy PEG-2 to Methoxy PEG-100) methoxides of polyhydric alcohol ethoxylates (e.g. glycereth-7 methoxide), pantothenol, gluconic acid salts and the like. Other humectant-type agents like that could also be employed include: 1,2,6-hexanetriol, acetamide mea, aluminum hydroxide, arginine pea, butoxypropanol, butylene glycol, dimethyl imidazolidinone, dimethylsilanol hyaluronate, dipotassium glycyrrhizate, erythritol, ethoxy-diglycol, fructose, glucamine, gluconic acid, glucose, glucose glutamate, glucuronic acid, glutamic acid, glycogen, glycyrrhizic acid, heilmoor clay, hexacosyl glycol, histidine, hyaluronic acid, hydrogenated honey, hydrogenated starch, hydrolysate, hydrolyzed collagen, hydrolyzed elastin, hydrolyzed glycosaminoglycans, hydrolyzed keratin, hydrolyzed silk, hydrolyzed soy protein, hydrolyzed wheat protein, hydroxyethyl sorbitol, inositol, inositol hexa-pea, lactamide mea, lactic acid, lactitol, lactose, lysine pea, magnesium pea, maltitol, manganese pea, mannitol, mel (honey extract), menthyl pea, methyl gluceth-10, methyl gluceth-20, pea (pidolic acid), lactamide, polydextrose, polyglucuronic acid, polyglyceryl sorbitol, potassium pea, ppg-20 methyl glucose ether, ppg-38-buteth-37, saccharide isomerate, serica, silk amino acids, sodium carboxymethyl chitin, sodium lactate, sodium mannuronate methylsilanol, sodium pea, sodium pea methylsilanol, sodium polyglutamate, soluble collagen, sorbitol, sucrose, tea-lactate, tea-pea, trehalose, trilactin, urea, xylitol, zea mays, zinc pea, and combinations thereof.
  • The addition of one or more emollients may affect the viscosity and stability of the compositions of the present invention. In some embodiments, a single emollient may be added to the composition. In some embodiments, two or more emollients may be added to the composition. While any of a variety of emollients may be added to the formulations of the present invention, some embodiments will include wax and oil type emollients either alone or combined with water soluble emollients. In some embodiments of the invention, emollient systems can be comprised of humectants in addition to occlusive wax and oil emollients in concentrations that achieve a moisturizing effect and which maintains and improves the condition of the skin upon repeated use. Emollients may be non-comedogenic and chosen to avoid skin irritation or sensitization reactions.
  • In addition to the antimicrobial effects attributable to the presence of alcohol in the compositions of the present invention, one or more other antimicrobial agents (“secondary antimicrobial agents”) may be added to enhance the antimicrobial properties of the compositions when they are used as pre-surgical hand scrubs or pre-surgical patient skin scrub replacements, for example. In other words, the foamed composition of the present invention can deliver a secondary antimicrobial agent to the skin. In some embodiments, the secondary antimicrobial agent is added in levels up to 10% by weight of the total composition. In some embodiments, it may be desirable to incorporate a secondary antimicrobial agent in the compositions of the invention to provide continued antimicrobial resistance to the growth or regrowth of the microorganisms following evaporation of the alcohol.
  • Non-limiting examples of suitable secondary antimicrobial agents include parachlorometaxylenol; triclosan; chlorhexidine and its salts such as chlorhexidine gluconate, poly hexamethylene biguanide and its salts such as poly hexamethylene biguanidine chloride, iodine, idodophors; fatty acid monoesters; poly-n-vinyl pyrrolidone-iodophors; silver oxide, silver and its salts, peroxides (e.g. hydrogen peroxide), antibiotics (e.g. neomycin, bacitracin, and polymixin B).
  • Additionally, other suitable ingredients can be used in the compositions of the invention to suppress the regrowth or possibly treat an infection of microorganisms, such as: 2,2-thiobis(4-chlorophenol); 4,4-isopropylidenediphenol; 5-amino-6-chloro-o-cresol; acetaminosalol; alcloxa; aldioxa; aluminum acetate; aluminum benzoate; aluminum diacetate; aluminum formate; aluminum phenolsulfonate; ammonium iodide; ammonium phenolsulfonate; benzisothiazolinone; benzotriazole; benzoxiquine; benzylparaben; berberine chloride; boric acid; cetethyl morpholinium ethosulfate; cetethyldimonium bromide; cetrimonium tosylate; cetylpyridinium chloride; chloramine-t; chlorothymol; cloflucarban; cocotrimonium chloride; colloidal sulfur; copper usnate; dedmhydantoin; dedm hydantoin dilaurate; dequalinium acetate; dequalinium chloride; dibromopropamidine diisethionate; dichloro-m-xylenol; dichlorophene; dichlorophenyl imidazoldioxolan; diiodomethyltolylsulfone; dimethyl hydroxymethylpyrazole; dimethylaminostyryl heptyl methyl thiazolium iodide; dodecylbenzyltrimonium chloride; domiphen bromide; ferulic acid; fluorosalan; glyoxal; hydroxymethyl dioxoazabicyclooctane; hydroxypropyl bistrimonium diiodide; ichthammol; isodecylparaben; isopropyl sorbate; lapyrium chloride; laurtrimonium trichlorophenoxide; lauryl iso-quinolinium bromide; lauryl isoquinolinium saccharinate; laurylpyridinium chloride; m-cresol; mandelic acid; MDM hydantoin; MEAa-iodine; melaleuca alternifolia; methyl-benzethonium chloride; mixed cresols; nonoxynol-12 iodine; nonoxynol-9 iodine; o-cresol; oxyquinoline benzoate; oxyquinoline sulfate; p-chlorophenol; p-cresol; PEG15 dedm hydantoin; PEG-15 dedm hydantoin stearate; PEG-5 dedm hydantoin; PEG-5 dedm hydantoin oleate; phenol; phenoxyethylparaben; phenyl salicylate; polymethoxy bicyclic oxazolidine; potassium iodide; potassium lactate; potassium phenoxide; potassium troclosene; quartronium-14; quaternium-24; quaternium-8; ricinoleamidopropyltrimonium methosulfate; sodium iodide; sodium p-chloro-m-cresol; sodium phenolsulfonate; sodium phenoxide; sodium usnate; steapyrium chloride; strontium peroxide; tea-sorbate; tetrabutyl ammonium bromide; thiabendazole; triacetin; undecylenamide dea; undecylenamide mea; undecylenamidopropyltrimonium methosulfate; undecyleneth-6; undecylenoyl peg-5 paraben; usnic acid; zinc acetate; zinc borate; zinc phenolsulfonate; zinc sulfate; zinc undecylenate; and combinations of the foregoing.
  • The following actives could also be of use to also reduce regrowth of microorganisms on skin: 2-bromo-2-nitropropane-1,3-dial; 4-hydroxybenzoic acid; 5-bromo-5-nitro-1,3-dioxane; 7-ethylbicyclooxazolidine; ammonium benzoate; ammonium bisulfite; ammonium propionate; ammonium sulfite; behentrimonium chloride; benzalkonium bromide; benzalkonium chloride; benzalkonium saccharinate; benzethonium chloride; benzoic acid; benzyl alcohol; benzylhemiformal; bromochlorophene; butyl benzoate; butylparaben; calcium benzoate; calcium paraben; calcium propionate; calcium salicylate; calcium sorbate; calcium undecylenate; cetalkonium chloride; cetearalkonium bromide; cetrimonium bromide; cetrimonium chloride; chloroacetamide; chlorobutanol; chlorophene; chloroxylenol; chlorphenesin; climbazole; dehydroacetic acid; diazolidinyl urea; dibromohexamidine isethionate; dichlorobenzyl alcohol; dimethyl oxazolidine; DMDM hydantoin; ethyl benzoate; ethylparaben; formaldehyde; formic acid; glutaral; hexamidine; hexamidine diisethionate; hexamidine paraben; hexetidine; hydrogenated tallowtrimonium chloride; imidazolidinyl urea; iodopropynyl butylcarbamate; isobutyl benzoate; isobutylparaben; isopropyl benzoate; isopropyl cresols; isopropylparaben; lauralkonium bromide; lauralkonium chloride; laurtrimonium bromide; laurtrimonium chloride; magnesium benzoate; magnesium propionate; magnesium salicylate; MEA o-phenylphenate; MEA-benzoate; MEA-salicylate; MEA-undecylenate; methenamine; methyl benzoate; methylchloroisothiazolinone; methyldibromo glutaronitrile; methylisothiazolinone; methylparaben; myristalkonium chloride; myristalkonium saccharinate; myrtrimonium bromide; o-cymen-5-01; o-phenylphenol; olealkonium chloride; p-chloro-m-cresol; phenoxyethanol; phenoxyisopropanol; phenyl benzoate; phenyl mercuric acetate; phenyl mercuric benzoate; phenyl mercuric borate; phenyl mercuric bromide; phenyl mercuric chloride; phenylparaben; piroctone olamine; polyaminopropyl biguanide; potassium benzoate; potassium butylparaben; potassium ethylparaben; potassium metabisulfite; potassium methylparaben; potassium o-phenylphenate; potassium paraben; potassium propionate; potassium propylparaben; potassium salicylate; potassium sorbate; potassium sulfite; propionic acid; propyl benzoate; propylparaben; quaternium-15; salicylic acid; sodium benzoate; sodium bisulfite; sodium butylparaben; sodium dehydroacetate; sodium ethylparaben; sodium formate; sodium hydroxymethylglycinate; sodium iodate; sodium metabisulfite; sodium methylparaben; sodium o-phenylphenate; sodium paraben; sodium propionate; sodium propylparaben; sodium salicylate; sodium sorbate; sodium sulfite; sodium undecylenate; sorbic acid; soytrimonium chloride; stearalkonium chloride; steartrimonium chloride; tallowalkonium chloride; tallowtrimonium chloride; thimerosal; triclocarban; triclosan; undecylenic acid; zinc pyrithione.
  • The present invention further encompasses embodiments incorporating antimicrobials such as benzoyl peroxide so that the composition may be useful as an acne medication, for example. In some embodiments, the compositions of the present invention may also be formulated with barrier compounds to form barrier creams and lotions. Materials which may be added to provide barrier protection for use as skin barriers to protect against diaper rash include but are not limited to 0.1 to 60% aldioxa, allantoin, aluminum acetate, aluminum hydroxide, bismuth subnitrate, boric acid, calamine, cellulose (microporous), cholecalciferol, cocoa butter, cod liver oil (in combination), colloidal oatmeal, cysteine hydrochloride, dexpanthenol, dimethicone, glycerin kaolin, lanolin (in combination), live yeast cell derivative, mineral oil, peruvian balsam, peruvian balsam oil, pertrolatum, protein hydrolysate (1-leucine, 1-isoleucine, 1-methionine, 1-phenylalanine, and 1-tyrosine), racemethionine, shark liver oil, sodium bicarbonate, sulfur, talc, tannic acid, topical starch, vitamin A, white petrolatum, zinc acetate, zinc carbonate and zinc oxide.
  • In some embodiments, the compositions of the invention may comprise one or more formulations containing antifungal agents for the treatment of fungal infections of the skin such as athlete's foot and the like.
  • While some embodiments will include one additional secondary antimicrobial agent, other embodiments of the invention can include two or more additional secondary antimicrobials. While the foregoing secondary antimicrobials can be added to the compositions individually or singly, combinations of two or more of the foregoing secondary antimicrobials are also contemplated within the scope of the invention.
  • In some embodiments, the compositions of the present invention may be formulated into non-aerosol products that can be dispensed from a reservoir using a hand-pump, for example, to dispense an amount of the composition whenever the hand pump is actuated. The amount of the composition dispensed by the pump may or may not be metered so that the amount of composition dispensed may or may not be consistent. Moreover, the compositions of the invention are not limited to being dispensed from only one type of dispenser or through only one type of hand pump.
  • In some embodiments, the compositions are capable of being formulated into an aerosol foam or a mousse by addition of propellant to the composition. Suitable propellants can be chosen from chlorofluorocarbons (CFCs), hydrochlorofluorocarbons (HCFCs), hydrofluorocarbons (HFCs), perfluorinated alkanes, and lower alkanes (C1-C5) as well as nitrous oxide dimethyl ether and other solvent-soluble propellants. Suitable lower alkanes include propane, butane, and isobutane, for example. In some embodiments, the propellant can comprise a 70/30 mixture of propane/isobutane. In order to produce an aerosol composition the composition is first formulated and charged into an appropriate pressure rated container. A suitable propellant may then be added to the composition under pressure at approximately 2-30% preferably 3-20% by volume. The propellant may form a separate layer on the composition or the propellant may be emulsified or miscible in the composition.
  • The compositions of the invention can be used in any of a variety of applications including use as a sanitizer for application to a surface. The compositions of the invention are suitable for use on mammalian skin including the human hands. In some embodiments, the compositions may be used as a pre-surgical hand scrub. In non-aerosol formulations of the invention, the compositions may be contained in a non-aerosol dispenser equipped with a conventional hand pump, and the composition may be pumped onto the hands or other areas of the body. The pumping action required to dispense the compositions will create a discrete volume of a dispensed composition in the form of a stable foam. Likewise, in embodiments comprising an aerosol, the aerosol formulation may be dispensed from a pressurized container in a discrete volume of foamed composition. After dispensing, the foam may be spread upon the surface of the skin to sanitize the skin, the hands or the like. While some residue may remain on the skin following evaporation of the alcohol component, the residue can comprise emollients or the like to provide a desired cosmetic effect. Consequently, the compositions of the invention provide a means for sanitizing skin in the form of a foamable composition which does not need to be rinsed from the skin following application of the foam to the area in need of sanitization. Alternatively, undesired residue remaining on the surface can be rinsed off with water, for example.
  • From the foregoing, it will be appreciated that the present invention also encompasses systems for dispensing the compositions comprising a reservoir and an amount of composition retained therein, and means for dispensing the composition from the reservoir.
  • The compositions of the present invention may be prepared by a variety of techniques and the ingredients may be added to one another in any order of addition. To ensure a composition of maximum stability, the components may be subjected to high shear (e.g. homogenized) for a limited time period.
  • EXAMPLES
  • The following non-limiting Examples are provided to illustrate features of the invention. are not intended to limit the scope of the invention. All percent amounts are weight/weight percent (wt/wt %) unless otherwise noted.
  • Preparation of Compositions
  • The compositions in the Examples were prepared in 60 gram samples by combining all components in a glass jar and rolling the jar overnight, on a mechanical roller. The foam builder was introduced to the mixture by first preparing a premix of the foam builder at ranges from 0.5% to 8.0% wt/wt, prepared in water/alcohol. The appropriate weight of premix was then added to the mixture containing the other components prior to the step of mixing by rolling overnight.
  • According to the Material Safety Data Sheets of certain dimethicone copolyol surfactants, the surfactants are known to contain significant quantities of PEO/PPO block copolymers of the type described herein as builders. These copolymers may be byproducts of the manufacturing process for the copolyol surfactants. The surfactants and builders used in the compositions of the Examples are listed in Tables 1 and 2.
  • TABLE 1
    Surfactants
    Trade Name INCI Name Surfactant Mfr. Mfr. Location
    Abil B 8852 PEG/PPG-4/12 Goldschmidt Hopewell, VA
    Dimethicone Chemical Corp.
    Abil B 8873 PEG/PPG-35/65 Goldschmidt Hopewell, VA
    Dimethicone 7,000 MW Chemical Corp.
    Dow 190 Fluid1 PEG/PPG-18/18 Dow Corning Midland, MI
    Dimethicone
    Dow 193 Fluid2 PEG-12 Dimethicone, Dow Corning Midland, MI
    Hydroxyl terminated
    Lambent MFF-164 Hydroxyl capped Lambent Gurnee, IL
    dimethicone copolyol Technologies Inc.
    Lambent Quat AD Silicone Quaternary 1 Lambent Gurnee, IL
    Technologies Inc.
    Lambent Quat AM Silicone Quaternary 2 Lambent Gurnee, IL
    (Myristyl) Technologies Inc.
    Lambent Syngard 300 Acrylic backbone Lambent Gurnee, IL
    polymer with Technologies Inc.
    dimethylsiloxane
    sidechains
    Lambent Wax WS-L Dimethicone copolyol Lambent Gurnee, IL
    Laurate Technologies Inc.
    Lambent Wax WS-p Silicone Copolyol Lambent Gurnee, IL
    Pelargonate Technologies Inc.
    Pecosil DCL Dimethicone Copolyol PCI Pheonix Somerville, NJ
    Lactate Chemical, Inc.
    Pecosil DCT Sodium Dimethicone PCI Pheonix Somerville, NJ
    Copolyol Acetyl Chemical, Inc.
    Methytaurate
    Q2-5220 Resin Modifier3 PEG/PPG-17/18 Dow Corning Midland, MI
    Dimethicone
    Silwax WD-IS Silicone Copolyol Lambent Gurnee, IL
    Isostearate Technologies Inc.
    Silwet 77 PEG Dimethicone, GE Silicones Midland, MI
    Methoxy Terminated,
    600 MW
    Silwet L-7001 EO/PO, Methoxy GE Silicones Wilton, CT
    terminated 20,000 MW
    Silwet L-7200 Dimethicone Copolyol GE Silicones Midland, MI
    Silwet L-7500 PPO Dimethicone, GE Silicones Midland, MI
    Butoxy Terminated,
    3,000 MW
    Silwet L-7602 PEG Dimethicone, GE Silicones Wilton, CT
    Methoxy Terminated,
    3000 MW
    Silwet L-7604 PEG Dimethicone, GE Silicones Midland, MI
    Hydroxy Terminated,
    4000 MW
    Silwet L-7605 PEG Dimethicone, GE Silicones Wilton, CT
    Methoxy Terminated,
    6000 MW
    Silwet L-7614 PEG Dimethicone, GE Silicones Wilton, CT
    Hydroxy Terminated,
    5000 MW
    3M ™ Silicones “Plus” Polysilicone-8 3M Company St. Paul, MN
    Polymer VS80
    1Dow 190 surfactant includes poly(ethylene oxide, propylene oxide) monoallyl ether acetate and polyether polyol acetate.
    2Dow 193 surfactant includes polyethylene oxide monoallyl ether.
    3Q2-5220 Resin Modifier includes poly(ethylene oxide, propylene oxide) monoallyl ether acetate; polyethylene glycol monoallyl ether acetate; and polyether polyol acetate.
  • TABLE 2
    Foam Builders
    Trade Name Description Supplier/Mfr. Mfr. Location
    Aqualon EC K100 Ethylcellulose Hercules Wilmington,
    DE
    Crothix Liquid PEG-150 Pentaerythrityl Croda Parsippany,
    tetrastearate (and) PEG-6 NJ
    Capric/Caprylic glycerides
    Ecopol 120-S Hydroxypropyl Guar Economy Houston, TX
    Polymers and
    Chemicals
    Ganex Butylated Polyvinyl ISP Wayne, NJ
    P-904LC Pyrrolidone Technologies
    Natrosol Plus Cetyl Hercules Wilmington,
    hydroxyethylcellulose DE
    Plasdone PVP K-120 Polyvinyl Pyrrolidone International Wayne, NJ
    Specialty
    Products
    Pluronic Ethylene Oxide/Propylene BASF Florham Park,
    F-108 Oxide Block Copolymer NJ
    Pluronic Ethylene Oxide/Propylene BASF Florham Park,
    F-127 Oxide Block Copolymer NJ
    Polyox WSR N12K poly(ethylene oxide) Dow Chemical Midland, MI
    Ave MW 1,000,000 Co.
    Polyox WSR N60K poly(ethylene oxide) Dow Chemical Midland, MI
    Ave MW 2,000,000 Co.
    Polyox WSR N-80 poly(ethylene oxide) Dow Chemical Midland, MI
    Ave MW 200,000 Co.
    Polyox WSR-301 poly(ethylene oxide) Dow Chemical Co. Midland, MI
    Ave MW 4,000,000
    PVP K-90 Polyvinyl Pyrrolidone (K BASF Florham Park,
    value 90) NJ
  • Equipment
  • Foam Pump—A foam pump nozzle was used to generate foam from each composition. The pump used was a pump dispenser, product Code F2, type F2-L11 255/150, available from Airspray International Inc. of North Pompano Beach, Fla.
  • Foam Collection vial—Vials were used to collect foam from the pump dispenser while the foam height was being measured. The vials were made of glass and were of either 40 or 80 mm height having a 25 mm internal diameter and a 27 mm outer diameter.
  • Test Methods Foam Height Test Procedure
  • The Foam Pump was used to assess the foam forming property of the compositions. The pump was rinsed between samples with deionized water by pumping water through the pump until it came out clear. The pump dip tube was removed from the water and then pumped dry of residual water and then placed in the composition to be tested. The pump was then pumped 3 times to prime the pump and then 3 more times to purge solution through the nozzle to ensure the system was ready. Finally, three pumps worth of foam were collected in a collection vial by pumping slowly at a speed of about 1 second for each pump. The vial containing the foam was placed on a flat surface, a timer was started and a small ruler with millimeter increments was used to measure the approximate height of the foam, ignoring the height of any remaining unfoamed composition. The time to measure the foam height usually took about 5 seconds. Any composition producing a foam which was not stable at least 5 seconds was considered unstable and rated 0 mm. The foam height was estimated to be the average height of the foam. A rating of 0 mm was given if the top of the solution was void of foam in any spot, usually the center. The foam height was recorded after 1, 3 and 5 minutes to determine the long term stability of the foam.
  • Foam Volume % Increase
  • The percentage of foam volume increase over the solution volume was calculated by measuring the foam height in millimeters, subtracting 5 mm from the foam height and dividing the result by 5 (the volume of the un-foamed pumped solution) and multiplying by 100%. Foam volume % increase measurements were made immediately following creation of the foam (e.g., after dispensing). Due to the difficulty in determining the exact foam surface, foam heights between 0-5 mm were reported as having a zero percent increase in foam volume.
  • Viscosity
  • Viscosity in centipoise (cP) was measured at 23° C. at ambient pressure using a Brookfield viscometer Model LVT equipped with a Brookfield LV spindle # 1 @ 60 rpm. All samples were allowed to equilibrate at 23° C. for 24 hours prior to measurement. The viscosity was taken at the lowest speed possible while staying within 10-100% of the viscometer range and more preferably between 20-80% of the range. The viscosity was read after one minute of testing. In all cases the sample size and container geometry was chosen to ensure that there were no wall effects. By “wall effects” it is meant the viscosity value is not affected by the container and is essentially equivalent to the viscosity taken in an infinitely large container. For this reason lower viscosity samples required a larger sample size to accommodate the larger spindles.
  • Examples 1-13
  • Examples 1-13 were prepared using various amounts of the surfactant Dow 190; plus a poly(ethylene oxide) (PEO) foam builder, available from Dow Chemical Company of Midland, Mich., under the trade name POLYOX™ WSR N12K; distilled water, and an alcohol solvent. Foam height measurements according to the above test method were taken for each sample. The foam height measurements and formulations for each of the Examples are set forth in Table 3.
  • TABLE 3
    Dow Foam Initial Foam Foam Foam
    190 Builder SDA1 Foam Height Height Height
    Surf. N12K Water (EtOH/ Height 1 min. 3 min. 5 min.
    Example Amt. % Amt. % Amt. % IPA) IPA2 mm mm mm mm
    1 1.00 0.060 43.94 55.00 32 30 24 23
    2 1.00 0.060 38.94 60.00 32 29 28 22
    3 1.00 0.060 35.17 63.77 35 33 29 20
    4 1.00 0.060 28.94 70.00 34 32 26 18
    5 1.00 0.060 23.94 75.00 28 26 21 17
    6 1.00 0.060 18.94 80.00 30 29 23 14
    7 1.00 0.060 43.94 55.00 36 35 32 28
    8 1.00 0.060 34.94 64.00 35 33 29 23
    9 0.50 0.060 35.44 64.00 25 23 20 14
    10 1.00 0.060 23.94 75.00 17 5 1 0
    11 1.00 0.060 18.94 80.00 35 32 25 16
    12 1.00 0.060 8.94 90.00 27 23 14 8
    13 1.00 0.060 34.94  0.00 64.003 26 25 21 14
    1SDA is Specially Denatured Alcohol (SDA-3-C): a mixture of 100 parts USP 200 proof Ethanol plus 5 parts isopropyl alcohol (IPA).
    2IPA is isopropyl alcohol, reagent grade.
    3n-propanol (reagent grade) was used instead of isopropyl alcohol.
  • Examples 14-32
  • Examples 14-32 were all prepared with the same alcohol solvent, foam builder, surfactant and water content. The only variation in Examples 14-32 was the type of surfactant used. The alcohol solvent was SDA-3-C and was present at 64.00%; the foam builder was PEO N12K (listed above) and was present at 0.06%; the water content was 25.50% and the amount of surfactant was 2.50%. Foam height data and foam volume % increased data are reported in Table 4 for each of the compositions.
  • TABLE 4
    Initial Foam Foam Foam
    Foam Height Height Height
    Height 1 min. 3 min. 5 min. Foam Volume
    Example Surfact. Trade Name mm mm mm Mm % Increase
    14 Dow 190 Fluid 45 42 28 12 800%
    15 Dow 193 Fluid 30 0 0 0 500%
    16 Abil B 8873 35 31 25 7 600%
    17 Lambent MFF-164 34 32 28 22 580%
    18 Lambent Quat AD 25 7 5 3 400%
    19 Lambent Quat AM 30 0 0 0 500%
    20 Lambent Wax WS-L 30 6 0 0 500%
    21 Lambent Wax WS-p 35 26 0 0 600%
    22 Pecosil DCL 34 20 0 0 580%
    23 Pecosil DCT 15 0 0 0 200%
    24 Q2-5220 Resin 30 27 23 14 500%
    Modifier
    25 Silwax WD-IS 10 0 0 0 100%
    26 Silwet 77 20 0 0 0 300%
    27 Silwet L-7001 35 34 29 16 600%
    28 Silwet L-7500 10 0 0 0 100%
    29 Silwet L-7602 38 5 0 0 660%
    30 Silwet L-7604 34 0 0 0 580%
    31 Silwet L-7605 30 0 0 0 500%
    32 Silwet L-7614 30 0 0 0 500%
  • Examples 33-53 and Comparative Examples C1-C6
  • The Examples 33-53 were all prepared with the same alcohol content of 65.00% USP 200 proof ethanol. The amounts and type of surfactant, the amount of foam builder and the water content were varied. Comparative Examples C1-C4 had no surfactant. Examples C5 and C6 had no builder. Formulations, initial foam height measurements and foam volume % increases are reported in Table 5.
  • TABLE 5
    Foam Initial Foam Foam
    Builder Foam Height Height Foam
    Surf. N12K Water Visc. Height 1 min. 3 min. Vol. %
    Example Surf. Type Amt. % Amt. % Amt. % Cp mm mm mm Increase
    C1 Silwet 0.00 0.000 35.00 3.4 0 0 0 0%
    L-7604
    33 Silwet 0.10 0.000 34.90 3.1 5 0 0 0%
    L-7604
    34 Silwet 1.00 0.000 34.00 3.5 10 5 1 100%
    L-7604
    C2 Silwet 0.00 0.060 34.94 3.8 0 0 0 0%
    L-7604
    35 Silwet 0.10 0.060 34.84 4.1 18 0 0 260%
    L-7604
    36 Silwet 1.00 0.060 33.94 4.0 21 3 0 320%
    L-7604
    37 Silwet 5.00 0.060 29.94 3.9 17 0 0 240%
    L-7604
    C3 Silwet 0.00 0.200 34.80 5.6 0 0 0 0%
    L-7604
    38 Silwet 0.10 0.200 34.70 5.5 18 0 0 260%
    L-7604
    39 Silwet 1.00 0.200 33.80 4.9 23 18 0 360%
    L-7604
    C4 Silwet 0.00 0.500 34.50 15.4 0 0 0 0%
    L-7604
    40 Silwet 0.10 0.500 34.40 16.5 16 0 0 220%
    L-7604
    41 Dow 190 1.00 0.060 33.94 3.9 40 38 35 700%
    42 Dow 190 1.00 0.000 34.00 1.5 15 9 6 200%
    43 Lambent 1.00 0.060 33.94 4.0 20 0 0 300%
    AD
    C5 Lambent 1.00 0.000 34.00 3.1 0 0 0 0%
    AD
    44 Lambent 1.00 0.060 33.94 4.1 34 30 8 580%
    WS-P
    45 Lambent 1.00 0.000 34.00 3.0 11 8 3 120%
    WS-P
    46 MFF-164 1.00 0.060 33.94 3.0 35 34 32 600%
    47 MFF-164 1.00 0.000 34.00 2.5 14 10 7 180%
    48 Pecosil 1.00 0.060 33.94 3.5 10 0 0 100%
    DCT
    C6 Pecosil 1.00 0.000 34.00 3.0 0 0 0 0%
    DCT
    49 Silwet 1.00 0.500 33.50 16.0 17 13 0 240%
    L-7604
    50 Lambent 1.00 0.060 34.94 nt1 33 32 30 560%
    Syngard
    300
    51 Abil B 1.00 0.060 34.94 nt 34 34 20 580%
    8852
    52 Silwet L- 1.00 0.060 34.94 nt 37 39 32 640%
    7200
    53 3M VS80 1.00 0.060 34.94 nt 26 18 14 420%
    1“nt” - not tested.
  • Examples 54-64
  • Examples 54-64 were all prepared with the same alcohol content of 65.00% USP 200 proof ethanol and the same surfactant content of 1.00% Q2-5220 Resin Modifier. The amounts and the type of foam builder were varied as was the water content. Composition, foam height and foam volume % increase are reported in Table 6.
  • TABLE 6
    Initial Foam Foam Foam
    Foam Foam Foam Height Height Height Foam
    Builder Builder Water Visc. Height 1 min. 3 min. 5 min. Vol. %
    Example Type Amt. % Amt. % Cp mm mm mm Mm Increase
    54 None 0.000 34.00 nt1 10 9 7 6 100%
    55 Crothix 0.080 33.92 nt 12 10 7 7 140%
    56 Crothix 0.300 33.70 4.9 12 9 8 6 140%
    57 Ganex 0.080 33.92 nt 11 9 8 8 120%
    P-904LC
    58 Ganex 0.300 33.70 7.4 10 8 8 7 100%
    P-904LC
    59 Pluronic 0.080 33.92 nt 10 7 6 6 100%
    F-108
    60 Pluronic 0.300 33.70 3.1 10 9 7 7 100%
    F-108
    61 Pluronic 0.080 33.92 nt 11 9 7 6 120%
    F-127
    62 Pluronic 0.300 33.70 8.6 13 10 9 9 160%
    F-127
    63 PVP K-90 0.080 33.92 nt 13 10 9 7 160%
    64 PVP K-90 0.300 33.70 4.3 9 9 6 6 80%
    1“nt”—not tested.
  • Examples 65-73
  • Examples 65-73 were all prepared with the same surfactant content of 1.00%, Dow 190. The amounts of foam builder, water content and USP 200 proof ethanol were all varied. Additionally the type of foam builder was also varied. Composition, foam height and foam volume % increase are reported in Table 7.
  • TABLE 7
    Initial Foam Foam Foam
    Foam Foam Foam Height Height Height Foam
    Builder Builder Water EtOH Height 1 min. 3 min. 5 min. Vol. %
    Example Type Amt. % Amt. % Amt. % mm mm mm Mm Increase
    65 None 0 34.00 65.00 15 13 11 9 200%
    66 Natrosol 0.06 33.98 64.96 13 10 8 6 160%
    Plus
    67 Natrosol 0.35 33.88 64.77 6 6 4 4 20%
    Plus
    68 Aqualon 0.06 33.98 64.96 15 11 10 8 200%
    EC K100
    69 Aqualon 0.35 33.88 64.77 13 10 8 8 160%
    EC K100
    70 Ecopol 0.06 33.98 64.96 12 9 8 7 140%
    120-S
    71 Ecopol 0.35 33.88 64.77 17 15 14 11 240%
    120-S
    72 PVP K-120 0.06 33.98 64.96 14 11 9 8 180%
    73 PVP K-120 0.35 33.88 64.77 9 7 6 6 80%
  • Examples 74-78
  • Examples 74-78 were formulated using PEO builders of different molecular weights. Dow 190 in an amount of 1.00% was used as the surfactant for all of the Examples 68-72. Formulation information and foam height data are given in Table 7. Fluid at an amount of 1.00%.
  • TABLE 8
    PEO PEO Initial Foam Foam Foam
    Foam Foam Foam Alcohol Foam Height Height Height
    Builder Builder Builder Water Solvent Height 1 min. 3 min. 5 min.
    Example Type MW Amt. % Amt. % Amt. %1 mm mm mm mm
    74 WSR-301 4,000,000 0.060 29.94 69.00 22 15 10 8
    75 N60K 2,000,000 0.060 29.94 69.00 28 24 20 14
    76 N12K 1,000,000 0.060 29.94 69.00 26 24 20 16
    77 WSR N- 200,000 0.060 34.94 64.00 14 13 11 9
    80
    78 none 0 0.0 35.00 64.00 9 9 8 8
    1The alcohol in Examples 68-70 was 190 proof USP ethanol. The alcohol in Examples 71-72 was SDA-3-C alcohol solvent.
  • Secondary Antimicrobials
  • Table 9 list various additional (secondary to alcohol) antimicrobials that were added to the formulations described in Examples 73-76.
  • TABLE 9
    Abbreviated
    Name Description Supplier/Mfr. Mfr. Location
    CHG 20% Chlorhexidine Medichem, S. A, Paramus, NJ
    Gluconate solution distributed by
    George Uhe
    Company, Inc.
    PCMX para-chloro-meta- Ferro Cleveland, OH
    xylenol Corporation
    Triclosan IRGASAN ® DP Ciba Greensboro, NC
    300
    Citric Acid Citric Acid MCB Reagents Rahway, NJ
    GML Glycerol Med-Chem Labs Galena, IL
    monolaurate
    SCL Sodium Capril Rita Corp. Woodstock, IL
    Lactylate
  • Examples 79-82
  • Examples 79-82 were formulated with the same components except that different secondary antimicrobials were used, as shown in Table 10. Foam height and foam volume % increase data are also set forth in Table 10.
  • TABLE 10
    Surf. Foam Initial Foam
    Dow Builder Alcohol Secondary Anti- Foam Height Foam
    190 WSR- Water SDA-3-C Anti- Micro. Height 5 min. Vol. %
    Example Amt. % N12K Amt. % Amt. % Micro. Amt. % mm mm Increase
    79 1.00 0.060 34.17 63.77 CHG 1.00 35 15 600%
    80 1.00 0.060 34.17 63.77 PCMX 1.00 40 15 700%
    81 1.00 0.060 34.17 63.77 Triclosan 1.00 36 12 620%
    82 1.00 0.060 31.97 63.77 GML + CA + 1.00 26 2 420%
    SCL1
    1Glycerol monolaurate at 1.00% + 2.00% citric acid + 0.1% sodium capril lactylate
  • Examples 83-107
  • Examples 83-107 were prepared to have the same alcohol content of 69.00% of USP 190 proof ethanol. The Dow 190 surfactant and WSR-301 foam builder were used in various amounts as described in Table 11. Additionally, one or more emollient was added to each of the formulations. Formulations, initial foam height measurements and foam volume % increase are reported in Table 11.
  • TABLE 11
    Surf. Foam Initial Foam Foam
    Dow Builder Foam Height Height Foam
    190 WSR 301 Water Height 1 min. 3 min. Vol. %
    Example Amt. % Amt. % Amt. % M11 M22 M33 mm mm mm Increase
    83 1.00 0.06 28.94 1.00 0.00 0.00 24 18 14 380%
    84 3.00 0.01 26.50 0.50 0.00 1.00 15 12 10 200%
    85 2.00 0.01 26.00 1.00 1.00 1.00 17 14 10 240%
    86 1.00 0.06 27.94 1.00 1.00 0.00 20 15 10 300%
    87 3.00 0.06 26.00 0.00 1.44 0.50 29 25 22 480%
    88 1.49 0.04 26.49 0.50 2.00 0.50 30 28 26 500%
    89 3.00 0.04 26.00 0.00 0.97 1.00 34 31 24 580%
    90 1.00 0.01 27.99 0.00 1.00 1.00 12 9 8 140%
    91 1.00 0.01 27.99 1.00 0.00 1.00 14 9 8 180%
    92 1.00 0.01 29.00 0.50 0.50 0.00 15 10 8 200%
    93 3.00 0.06 26.00 1.00 0.94 0.00 25 20 18 400%
    94 1.94 0.06 26.00 1.00 2.00 0.00 30 28 23 500%
    95 1.00 0.06 28.94 0.00 0.00 1.00 27 22 16 440%
    96 1.00 0.01 26.99 1.00 2.00 0.00 15 11 9 200%
    97 1.50 0.01 29.00 0.00 0.00 0.50 15 10 10 200%
    98 3.00 0.01 26.00 0.00 1.99 0.00 15 13 9 200%
    99 2.97 0.06 26.00 1.00 0.00 0.97 25 23 18 400%
    100 3.00 0.01 26.00 0.00 1.99 0.00 16 14 12 220%
    101 2.00 0.06 27.94 0.00 0.00 1.00 30 22 17 500%
    102 1.91 0.06 27.10 0.51 0.91 0.51 36 31 25 620%
    103 1.00 0.01 26.99 0.00 2.00 1.00 14 10 7 180%
    104 1.00 0.06 27.94 0.00 2.00 0.00 30 25 21 500%
    105 3.00 0.01 26.99 1.00 0.00 0.00 15 12 8 200%
    106 1.00 0.06 26.00 0.97 1.97 1.00 31 30 25 520%
    107 2.00 0.06 27.94 1.00 0.00 0.00 31 28 20 520%
    1M1 was Myristyl Alcohol, available from Sasol North America, Westlake, LA.
    2M2 was G-18-0, glycereth 18 ethylhexanoate, available from Global 7, Franklin, NJ.
    3M3 was Glycerol, available from from Dow Chemical, Midland MI.
  • Examples 108-113
  • Example 108-113 were prepared with the same alcohol content of 63.77% SDA-3-C; the same amount of surfactant, Dow 190 at 1.00% and the same foam builder PEO, N12K, at an amount of 0.060%, The type and amount emollient was varied, as was the amount of water. Initial foam height measurements and foam volume % increase were taken and are reported in Table 12.
  • TABLE 12
    Initial Foam Foam Foam
    Foam Height Height Height Foam
    Water Height 1 min. 3 min. 5 min. Vol. %
    Example Amt. % M11 M42 M53 mm Mm mm mm Increase
    108 34.67 0.50 0.00 0.00 38 33 28 18 660%
    109 34.17 1.00 0.00 0.00 37 34 23 13 640%
    110 33.17 2.00 0.00 0.00 30 28 24 15 500%
    111 32.17 3.00 0.00 0.00 30 24 24 15 500%
    112 32.17 0.00 3.00 0.00 36 35 30 21 620%
    113 32.17 0.00 0.00 3.00 35 34 26 15 600%
    1M1: Myristyl Alcohol, available from Sasol North America, Westlake, LA.
    2M4: Triethyl Citrate, NF available from Morflex Inc. of Greensboro, NC.
    3M5: Acetyl Triethyl Citrate, NF available from Morflex Inc. of Greensboro NC.
  • TABLE 13
    Components for Comparative Examples C7-C16
    Trade/Abbrev. Name Description Supplier/Mfr. Mfr. Location
    Monateric CAB-NPB Cocamido Propyl Uniqema Wilmington, DE
    Betaine
    BRIJ 52 PEO 2 cetyl alcohol Uniqema Wilmington, DE
    Silwet L-7200 Dimethicone Copolyol GE Silicones Midland, MI
    19,000 MW 75/25
    EO/PO Ratio
    Standamid KD Cocamide DEA Kraft Chemical Co. Melrose Park, IL
    Super Solen PEG-75 PEG-75 Lanolin Croda Parsippany, NJ
    Myristyl Alcohol Myristyl Alcohol Sasol Westlake, LA
    Tween 61 PEO 4 Sorbitan mono Uniqema Wilmington, DE
    stearate
    Dermal DIA Diisopropyl Adipate Alzo International Sayreville, NJ
    Cetearyl alcohol 50:50 wt blend of Cetyl Croda Parsippany, NJ
    and Stearyl alcohol
    PG Propylene Glycol Dow Chemical Midland, MI
    Methocel 40-100 Hydroxypropyl Dow Chemical Midland, MI
    methylcellulose
    Klucel Hydroxy Propyl Hercules Wilmington, DE
    Cellulose
    Ritapro 300 cetearyl alcohol and Rita Corp. Woodstock, IL
    ceteareth-20
    Brij 72 Steareth-2 Uniqema Wilmington, DE
    Brij 721 Steareth-21 Uniqema Wilmington, DE
    Polysorbate 80 Polysorbate 80 Sigma Chemical St. Louis, MO
    Co.
    PEG 400 Polyethylene glycol Dow Chemical Midland, MI
    400 MW
    Sodium Dodecyl Sodium Dodecyl Pfaltz and Bauer Waterbury, CT
    benzene sulfonate benzene sulfonate
    Citric Acid Citric Acid MCB Reagents Rahway, NJ
    Glycerol monolaurate Glycerol monolaurate Med-Chem Labs Galena, IL
    Sodium Capril Sodium Capril Rita Corp. Woodstock, IL
    Lactylate Lactylate
  • Comparative Examples C7-C8
  • Comparative Examples C7 and C8 were tested for initial foam height after being prepared using the materials of Table 13 in the amounts listed in Tables 14A and 14B.
  • TABLE 14A
    USP Initial
    CHG Ethanol Foam
    Soln. Cetearyl Tween 190 Height
    Example 20% alcohol 61 PG Proof Water mm
    C7 5.00 2.50 0.50 3.00 57.00 22.80 0
  • TABLE 14B
    Myristyl Brij Initial Foam
    Example alcohol 52 Glycerol IPA Water Height mm
    C8 3.00 0.80 2.50 60.00 25.40 0
  • Comparative Examples C9-C11
  • Comparative Examples C9, C10 and C11 were prepared using the materials listed in Table 13 in the amounts listed in Table 15 and were tested using the standard Foam Height procedure described above. The Initial Foam Height for each Comparative Example C9-C11, was 0 mm.
  • TABLE 15
    USP
    Cocamido Kraft Ethanol
    Silwet Propyl Standamid Methocel PEG-75 200
    Ex. # L-7200 Betaine KD 40-100 Lanolin Glycerin IPA Proof Water
    C9 0.20 10.00 7.00 1.00 3.00 0.20 60.00 17.97
    C10 0.25 10.00 7.00 1.00 3.00 0.05 60.00 18.07
    C11 0.25 10.00 7.00 1.00 3.00 0.05 70.0 8.07
  • Comparative Examples C12-C14
  • Comparative Examples C12, C13 and C14 were prepared using various materials of Table 13 in the amounts listed in Table 16 and were tested using the standard Foam Height procedure described above.
  • TABLE 16
    USP Initial
    Ethanol CHG Foam
    Ritapro Brij Brij 200 Wa- 20% Height
    Ex. # 300 72 721 Klucel Proof ter Soln. mm
    C12 2.50 1.88 0.625 0.20 60.00 14.62 0.060 0
    C13 2.50 1.88 0.625 0.20 60.00 24.71 0.200 0
    C14 2.50 1.88 0.625 0.20 60.00 32.23 0.200 0
  • Comparative Examples C15-C16
  • Comparative Examples C15 and C16 were prepared using various materials of Table 13 in the amounts listed in Table 17 and were tested using the standard Foam Height procedure described above.
  • TABLE 17
    Sodium USP Initial
    Dodecyl Ethanol Foam
    benzene Polysorbate Propylene 200 Height
    Ex. # sulfonate 80 Glycerol PEG 400 glycol Proof Water mm
    C15 3.00 1.00 1.50 0.50 0.00 55.00 37.25 0
    C16 3.00 3.00 0.00 0.00 2.00 60.00 31.00 0
  • Various modifications and alterations of the present invention will be apparent to those skilled in the art without departing from the scope and spirit of the present invention. The Examples described in this application are illustrative of the possibilities of varying the type, quantity and ratio of composition as well as the methods for making formulations of the present invention.

Claims (1)

1. A composition, comprising:
(A) Monohydric alcohol in an amount sufficient to provide antimicrobial activity;
(B) Surfactant comprising a dimethicone surfactant; and
(C) Builder, the builder in an amount sufficient to provide stability or to improve the stability of a foam formed from the composition.
US12/552,126 2005-06-13 2009-09-01 Foamable alcohol compositions, systems and methods of use Abandoned US20090326076A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/552,126 US20090326076A1 (en) 2005-06-13 2009-09-01 Foamable alcohol compositions, systems and methods of use
US12/878,786 US20100331411A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use
US12/878,793 US20100327013A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/151,563 US7651990B2 (en) 2005-06-13 2005-06-13 Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US12/552,126 US20090326076A1 (en) 2005-06-13 2009-09-01 Foamable alcohol compositions, systems and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/151,563 Continuation US7651990B2 (en) 2005-06-13 2005-06-13 Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/878,786 Continuation US20100331411A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use
US12/878,793 Continuation US20100327013A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use

Publications (1)

Publication Number Publication Date
US20090326076A1 true US20090326076A1 (en) 2009-12-31

Family

ID=37075262

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/151,563 Active US7651990B2 (en) 2005-06-13 2005-06-13 Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US12/552,126 Abandoned US20090326076A1 (en) 2005-06-13 2009-09-01 Foamable alcohol compositions, systems and methods of use
US12/878,786 Abandoned US20100331411A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use
US12/878,793 Abandoned US20100327013A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/151,563 Active US7651990B2 (en) 2005-06-13 2005-06-13 Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/878,786 Abandoned US20100331411A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use
US12/878,793 Abandoned US20100327013A1 (en) 2005-06-13 2010-09-09 Foamable alcohol compositions, systems and methods of use

Country Status (12)

Country Link
US (4) US7651990B2 (en)
EP (1) EP1893167A1 (en)
JP (1) JP5266049B2 (en)
KR (1) KR101389199B1 (en)
CN (1) CN101198308B (en)
AU (1) AU2006259687B2 (en)
BR (1) BRPI0613333A2 (en)
CA (1) CA2610945C (en)
MX (1) MX2007015768A (en)
NO (1) NO20080261L (en)
TW (1) TW200710220A (en)
WO (1) WO2006138111A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211066A1 (en) * 1995-06-22 2003-11-13 3M Innovative Properties Company Stable hydroalcoholic compositions
US20080108704A1 (en) * 1997-01-09 2008-05-08 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US20100160453A1 (en) * 2003-09-29 2010-06-24 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions
US7803390B2 (en) 1995-06-22 2010-09-28 3M Innovative Properties Company Stable hydroalcoholic compositions
US8124115B2 (en) 2004-12-21 2012-02-28 Dep Ip Limited Alcoholic pump foam
US8263098B2 (en) 2005-03-07 2012-09-11 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
US9089129B2 (en) 2011-10-07 2015-07-28 American Sterilizer Company Non-aerosol foaming alcohol hand sanitizer
US9414586B2 (en) 2008-07-24 2016-08-16 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US10799433B2 (en) 2016-04-20 2020-10-13 S. C. Johnson & Son, Inc. Foaming antimicrobial compositions

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566460B2 (en) * 1995-06-22 2009-07-28 3M Innovative Properties Company Stable hydroalcoholic compositions
US7747507B2 (en) 1996-05-23 2010-06-29 Ticketmaster L.L.C. Computer controlled auction system
US9740988B1 (en) 2002-12-09 2017-08-22 Live Nation Entertainment, Inc. System and method for using unique device indentifiers to enhance security
US10366373B1 (en) 2002-12-09 2019-07-30 Live Nation Entertainment, Incorporated Apparatus for access control and processing
US9477820B2 (en) 2003-12-09 2016-10-25 Live Nation Entertainment, Inc. Systems and methods for using unique device identifiers to enhance security
US8078483B1 (en) 2003-12-16 2011-12-13 Ticketmaster Systems and methods for queuing access to network resources
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
EP1702605B1 (en) * 2005-03-18 2009-11-04 Tokuyama Corporation Curable composition
US9608929B2 (en) 2005-03-22 2017-03-28 Live Nation Entertainment, Inc. System and method for dynamic queue management using queue protocols
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
FR2894467B1 (en) * 2005-12-08 2008-02-15 Oreal FOESENED COSMETIC COMPOSITION OF LOW DENSITY
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
AU2007212489B2 (en) 2006-02-07 2013-01-31 Ticketmaster Methods and systems for reducing burst usage of a networked computer system
US20070185216A1 (en) * 2006-02-09 2007-08-09 Marcia Snyder Antiviral method
US9629361B2 (en) * 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US8119115B2 (en) 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US8450378B2 (en) * 2006-02-09 2013-05-28 Gojo Industries, Inc. Antiviral method
US20070207104A1 (en) * 2006-03-06 2007-09-06 Borish Edward T Antimicrobial esters
US7723279B2 (en) * 2006-08-23 2010-05-25 The Clorox Company Foamable compositions containing alcohol
US20100189809A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Compositions Containing Alcohol
MX2009003455A (en) * 2006-10-02 2009-09-25 Dow Global Technologies Inc High alcohol-content foams.
US8580860B2 (en) 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
US8065773B2 (en) 2007-04-02 2011-11-29 Bard Access Systems, Inc. Microbial scrub brush
US8336152B2 (en) 2007-04-02 2012-12-25 C. R. Bard, Inc. Insert for a microbial scrubbing device
US9192449B2 (en) 2007-04-02 2015-11-24 C. R. Bard, Inc. Medical component scrubbing device with detachable cap
US8053399B2 (en) * 2007-08-30 2011-11-08 Kimberly-Clark Worldwide, Inc. Foamable compositions
ES2556127T3 (en) * 2007-08-31 2016-01-13 The Procter & Gamble Company Liquid acid hard surface cleaning composition
US9807096B2 (en) 2014-12-18 2017-10-31 Live Nation Entertainment, Inc. Controlled token distribution to protect against malicious data and resource access
EP2039748A1 (en) * 2007-09-17 2009-03-25 The Procter and Gamble Company Process of treating inclined hard surface
EP2039747A1 (en) 2007-09-17 2009-03-25 The Procter and Gamble Company Process for treating hard surface
US9381150B2 (en) * 2008-03-07 2016-07-05 Kimberly-Clark Worldwide, Inc. Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
US8696820B2 (en) 2008-03-31 2014-04-15 Bard Access Systems, Inc. Method of removing a biofilm from a surface
US8069523B2 (en) 2008-10-02 2011-12-06 Bard Access Systems, Inc. Site scrub brush
JP2010111609A (en) * 2008-11-05 2010-05-20 Kao Corp Hand and finger-disinfecting agent composition
US20100135949A1 (en) * 2008-12-01 2010-06-03 Becton, Dickinson And Company Antimicrobial compositions
MX2011010308A (en) 2009-04-01 2012-01-20 Bard Inc C R Microbial scrubbing device.
DE102010004950A1 (en) * 2010-01-18 2011-07-21 Remis Gesellschaft für Entwicklung und Vertrieb von technischen Elementen mbH, 50829 Cooling shelf with door device
CA2828086C (en) 2010-03-10 2018-07-31 Nuvo Research Inc. Foamable formulation
WO2011149645A1 (en) 2010-05-28 2011-12-01 Nuvo Research Inc. Topical etoricoxib formulation
US10096161B2 (en) 2010-06-15 2018-10-09 Live Nation Entertainment, Inc. Generating augmented reality images using sensor and location data
US9781170B2 (en) 2010-06-15 2017-10-03 Live Nation Entertainment, Inc. Establishing communication links using routing protocols
EP2583235A4 (en) 2010-06-15 2014-01-22 Ticketmaster L L C Methods and systems for computer aided event and venue setup and modeling and interactive maps
US9949477B2 (en) 2010-12-30 2018-04-24 Kimberly-Clark Worldwide, Inc. Durable antimicrobial composition
US20120171301A1 (en) * 2010-12-30 2012-07-05 David William Koenig Durable Antimicrobial Composition Including a Surfactant
US20120171300A1 (en) * 2010-12-30 2012-07-05 David William Koenig Durable Antimicrobial Composition Including a Surfactant
US9161531B2 (en) 2011-02-23 2015-10-20 Donald R. Korb High alcohol content sanitizer
EP2685820A4 (en) * 2011-03-15 2014-08-27 Thompson Cooper Lab Llc Compositions and methods for treatment of infections
US9295251B1 (en) 2011-04-08 2016-03-29 Safehands Solutions, LLC Synergistic antimicrobial compositions of PCMX and carboxylic acid and related methods
US8304375B1 (en) * 2011-10-13 2012-11-06 Kimberly-Clark Worldwide, Inc. Foaming formulations including silicone polyesters
US8865195B2 (en) * 2011-10-13 2014-10-21 Kimberly-Clark Worldwide, Inc. Foaming formulations and cleansing products including silicone polyesters
JP2015517978A (en) 2012-02-24 2015-06-25 ゴジョ・インダストリーズ・インコーポレイテッド Antibacterial and foaming alcohol composition
AU2013240259B2 (en) 2012-03-30 2016-09-22 Gojo Industries, Inc. Antimicrobial alcohol foam compositions and methods of preparation
US20130255061A1 (en) * 2012-04-03 2013-10-03 Becton, Dickinson And Company Systems and methods for applying a novel antimicrobial coating material to a medical device
US9352119B2 (en) 2012-05-15 2016-05-31 Becton, Dickinson And Company Blood control IV catheter with antimicrobial properties
GB201211702D0 (en) 2012-07-02 2012-08-15 Reckitt Benckiser Llc Sprayable aqueous alcoholic microbicidal compostions comprising zinc ions
GB201211701D0 (en) 2012-07-02 2012-08-15 Reckitt Benckiser Llc Aqueous alcoholic microbicidal compositions comprising zinc ions
GB201211691D0 (en) 2012-07-05 2012-08-15 Reckitt Benckiser Llc Sprayable aqueous alcoholic microbicidal compositions comprising zinc ions
GB201211688D0 (en) 2012-07-02 2012-08-15 Reckitt Benckiser Llc Aqueous alcoholic microbicidal compositions comprising zinc ions
US9579486B2 (en) 2012-08-22 2017-02-28 Becton, Dickinson And Company Blood control IV catheter with antimicrobial properties
US9707162B2 (en) 2012-11-30 2017-07-18 Reckitt & Colman (Overseas) Limited Microbicidal personal care compositions comprising metal ions
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
FI128215B (en) * 2013-05-28 2019-12-31 Argenlab Global Ltd Low alcohol content disinfection foams
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
WO2015030768A1 (en) * 2013-08-29 2015-03-05 Colgate-Palmolive Company Aqueous liquid compositions
WO2015061552A1 (en) * 2013-10-23 2015-04-30 Gojo Industries, Inc. Foamable alcoholic compositions containing branched foaming surfactants
CA2940494C (en) 2014-03-14 2022-11-08 Gojo Industries, Inc. Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US9970303B2 (en) 2014-05-13 2018-05-15 Entrotech, Inc. Erosion protection sleeve
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
WO2016005922A1 (en) * 2014-07-09 2016-01-14 99 Holding S.A.R.L. Disinfecting composition comprising silver ions and a quaternary salt
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2016085906A1 (en) * 2014-11-25 2016-06-02 Gojo Industries, Inc. Foamable alcoholic sanitizing compositions with branched polyethoxylated dimethicone foaming surfactants and isopropanol
CN104490630A (en) * 2014-12-09 2015-04-08 南阳市汇博生物技术有限公司 No-washing foam hand disinfection solution and preparation method thereof
EP3280461B1 (en) 2015-04-06 2020-06-17 3M Innovative Properties Company Removable film forming gel compositions and methods for their application
US10813357B1 (en) 2015-05-26 2020-10-27 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms
JP6577322B2 (en) * 2015-10-07 2019-09-18 エア・ウォーター・ゾル株式会社 Aerosol preparation containing ethanol
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
EP3374635B1 (en) 2015-11-12 2019-07-03 Gojo Industries, Inc. Sequentially activated multi-diaphragm foam pump
US10065199B2 (en) 2015-11-13 2018-09-04 Gojo Industries, Inc. Foaming cartridge
JP6834376B2 (en) * 2015-11-17 2021-02-24 日油株式会社 Surfactant composition
US10080466B2 (en) 2015-11-18 2018-09-25 Gojo Industries, Inc. Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems
US10080467B2 (en) 2015-11-20 2018-09-25 Gojo Industries, Inc. Foam dispensing systems, pumps and refill units having high air to liquid ratios
US10080468B2 (en) 2015-12-04 2018-09-25 Gojo Industries, Inc. Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems
AU2017217986B2 (en) * 2016-02-11 2022-03-17 Gojo Industries, Inc. High quality non-aerosol hand sanitizing foam
US10441115B2 (en) 2016-02-11 2019-10-15 Gojo Industries, Inc. High quality non-aerosol hand sanitizing foam
JP6164543B1 (en) * 2016-02-17 2017-07-19 株式会社アウラ Photosensitive hair dye
US10912426B2 (en) 2016-04-06 2021-02-09 Gojo Industries, Inc. Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems
US10143339B2 (en) 2016-04-06 2018-12-04 Gojo Industries, Inc. Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems
USD815838S1 (en) 2016-07-15 2018-04-24 Colgate-Palmolive Company Toothbrush
US20190381208A1 (en) 2016-10-13 2019-12-19 3M Innovative Properties Company Removable Film Forming Gel Compositions Featuring Adhesion Promoters
US11628129B2 (en) 2017-04-04 2023-04-18 Gojo Industries, Inc. Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems
WO2019006217A1 (en) 2017-06-28 2019-01-03 Collidion, Inc. Compositions, methods and uses for cleaning, disinfecting and/or sterilizing
MX2020002202A (en) * 2017-09-04 2020-07-20 Dow Global Technologies Llc Powder laundry detergent formulation.
MX2020007533A (en) 2018-01-14 2021-01-15 Collidion Inc Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating.
DE102018200732A1 (en) * 2018-01-17 2019-07-18 B. Braun Melsungen Ag Composition for the disinfection of skin and / or hands
US11653645B2 (en) 2018-05-10 2023-05-23 Protair-X Health Solutions Inc. Foam sanitizer composition
CN109288822A (en) * 2018-08-24 2019-02-01 杭州氢源素生物科技有限公司 A kind of viral Special sterilizing liquid and preparation method thereof containing polyglycerol ester
WO2020098899A1 (en) * 2018-11-14 2020-05-22 MEKHIMAR, Abdelrahman Amin Abdelgawwad The preventive shoes
CN113164511A (en) * 2018-12-19 2021-07-23 日东嵄帝科株式会社 Foaming external composition
CN109646712B (en) * 2018-12-26 2021-08-20 北京安德普泰医疗科技有限公司 Colloidal sulfur liquid dressing and preparation method thereof
CN109371667B (en) * 2018-12-27 2021-05-14 福建省健为医疗用品有限公司 Scouring reagent and bleaching method for pure cotton non-woven fabric and pure cotton non-woven fabric
CA3128303A1 (en) * 2019-02-21 2020-08-27 Chemetall Gmbh An anti-rust composition for metal surface and a method of anti-rust treatment on metal surface
US20220241458A1 (en) 2019-05-31 2022-08-04 Kindeva Drug Delivery L.P. Removable Film-Forming Gel Compositions Featuring Adhesion Promoters
BR112023006148A2 (en) * 2020-10-23 2023-05-09 Chattem Inc FOAMABLE COMPOSITION, ITS USE AND PROCESS FOR PREPARING IT
WO2023152136A1 (en) * 2022-02-14 2023-08-17 Unilever Ip Holdings B.V. A foaming acidic hard surface cleaning composition
CN115414271B (en) * 2022-08-09 2023-09-15 纳爱斯浙江科技有限公司 Shower gel with good skin feel after use

Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
US4454060A (en) * 1983-06-09 1984-06-12 Colgate-Palmolive Company Liquid detergent composition with a cationic foam stabilizing copolymer containing pendant quaternary nitrogen groups and pendant hydrophobic groups
US4559226A (en) * 1983-09-06 1985-12-17 Bernel Chemical Company Inc. Self-emulsifying alkoxylate esters
US4584189A (en) * 1984-09-28 1986-04-22 Hercules Incorporated Bactericidal toothpastes
US4613592A (en) * 1984-01-09 1986-09-23 Lever Brothers Company Skin treatment composition
US4772592A (en) * 1984-01-09 1988-09-20 Lever Brothers Company Skin treatment composition
US4839166A (en) * 1986-05-16 1989-06-13 L'oreal Cosmestic compositions containing a cationic polymer and an anionic polymer as thickening agent
US4839167A (en) * 1986-09-18 1989-06-13 Kao Corporation Emulsion type hair cosmetic
US4857302A (en) * 1987-02-20 1989-08-15 Decker Jr Donald F Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide
US4956170A (en) * 1989-06-28 1990-09-11 S. C. Johnson & Son, Inc. Skin moisturizing/conditioning antimicrobial alcoholic gels
US4986922A (en) * 1990-04-04 1991-01-22 Dow Corning Corporation Softening compositions including quaternary ammonium functional siloxanes
US5104646A (en) * 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5180584A (en) * 1990-01-31 1993-01-19 L'oreal Washing compositions based on insoluble silicones and on a surface-active agent of the polyoxyalkylenated carboxylic ether acid type, and their application in cosmetics and in dermatology
US5232691A (en) * 1989-04-26 1993-08-03 Lemole Gerald M Protective gel composition
US5362484A (en) * 1992-06-10 1994-11-08 Alberto-Culver Company Hair care composition for conditioning hair with silicone oil
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
US5567428A (en) * 1993-08-27 1996-10-22 The Procter & Gamble Company Topical personal care composition containing polysiloxane-grafted adhesive polymer and drying aid
US5612324A (en) * 1992-05-05 1997-03-18 The Procter & Gamble Company Method for treating acne
US5626853A (en) * 1994-03-14 1997-05-06 L'oreal Aqueous make-up gel containing organopolysiloxane
US5629006A (en) * 1994-06-27 1997-05-13 Becton, Dickinson And Company Skin disinfecting formulations
US5756077A (en) * 1996-09-13 1998-05-26 Avlon Industries, Inc. Hair protectant composition and process for preserving chemically processed hair during subsequent chemical processing
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US5919439A (en) * 1993-08-23 1999-07-06 The Procter & Gamble Company Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
US5928993A (en) * 1995-04-28 1999-07-27 Akzo Nobel Nv Aqueous composition, and the use of a wetting-improving agent
US5955408A (en) * 1996-07-10 1999-09-21 Steris Inc. Triclosan skin wash with enhanced efficacy
US5972356A (en) * 1997-11-05 1999-10-26 The Procter & Gamble Company Personal care compositions
US5980876A (en) * 1991-08-19 1999-11-09 The Procter & Gamble Company Hair spray compositions
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6255265B1 (en) * 1998-10-13 2001-07-03 Lever Brothers Company, Division Of Conopco, Inc. Low synthetic soap bars comprising organic salts and polyalkylene glycol
US6333039B1 (en) * 1998-09-25 2001-12-25 Gojo Industries, Inc. Opaque skin sanitizing composition
US6342470B1 (en) * 2000-04-26 2002-01-29 Unilever Home & Personal Care Usa Bar comprising soap, fatty acid, polyalkylene glycol and protic acid salts in critical ratios and providing enhanced skin care benefits
US20020028187A1 (en) * 1999-05-07 2002-03-07 Natalia Nekludoff Low voc hair spray compositions having enhanced styling benefits
US6383997B1 (en) * 2001-07-02 2002-05-07 Dragoco Gerberding & Co. Ag High lathering antibacterial formulation
US6410005B1 (en) * 2000-06-15 2002-06-25 Pmd Holdings Corp. Branched/block copolymers for treatment of keratinous substrates
US20020098159A1 (en) * 2000-01-20 2002-07-25 Wei Karl Shiqing Antimicrobial compositions
US20020108640A1 (en) * 2000-06-14 2002-08-15 The Procter & Gamble Company Process for cleaning a surface
US20020151446A1 (en) * 2001-02-06 2002-10-17 Playtex Products, Inc. Mild foaming cleanser composition
US6472356B2 (en) * 2000-10-20 2002-10-29 Vinod K. Narula Sanitizing hand cleanser comprising an organic alcohol and silicone based materials
US20020160924A1 (en) * 1999-06-15 2002-10-31 The Procter & Gamble Company Cleaning compositions
US20020177535A1 (en) * 2001-02-06 2002-11-28 Playtex Products, Inc. Cleansing compositions with milk protein and aromatherapy
US6491840B1 (en) * 2000-02-14 2002-12-10 The Procter & Gamble Company Polymer compositions having specified PH for improved dispensing and improved stability of wrinkle reducing compositions and methods of use
US6497864B1 (en) * 1998-11-26 2002-12-24 L'ORéAL S.A. Hairstyling composition comprising a polymer with particular characteristics and a non-ionic polymer
US6524494B2 (en) * 2001-02-02 2003-02-25 Givaudan Sa Compositions to enhance fabric freshness and appearance
US6524594B1 (en) * 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
US6537952B2 (en) * 2000-08-31 2003-03-25 Unilever Home And Personal Care, Usa Division Of Conopco, Inc. Foaming anti-bacterial cleansing skin product with low water insoluble emollients and foam dispenser
US20030134761A1 (en) * 2001-07-20 2003-07-17 L'oreal Foaming composition based on silica and on cationic polymer
US6617294B2 (en) * 2000-10-20 2003-09-09 Vinod K. Narula Waterless sanitizing hand cleanser
US6638527B2 (en) * 2000-04-17 2003-10-28 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Substantially dry cleansing product of improved latherability and wet flexibility
US6641825B2 (en) * 2000-03-01 2003-11-04 Henkel Kommanditgesellschaft Auf Aktien Skin cleansing gel having a heating effect
US20030211066A1 (en) * 1995-06-22 2003-11-13 3M Innovative Properties Company Stable hydroalcoholic compositions
US20030235550A1 (en) * 2002-06-21 2003-12-25 Pan Robert Ya-Lin Antimicrobial compositions, products and methods employing same
US6685952B1 (en) * 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
US6730621B2 (en) * 2001-05-14 2004-05-04 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Damp cleansing wipe
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US20040191274A1 (en) * 2003-03-28 2004-09-30 Grayson Michael L. Topical composition
US6818603B2 (en) * 2002-08-14 2004-11-16 Johnson & Johnson Consumer Companies, Inc. Cleansing bar containing discrete elements
US20040247685A1 (en) * 2001-10-23 2004-12-09 Shanta Modak Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
US20050003990A1 (en) * 2002-11-27 2005-01-06 Smith Kim R. Foam cleaning composition, method for foaming a cleaning composition, and foam dispenser
US20050030917A1 (en) * 2001-08-17 2005-02-10 Amit Haller Device, system, method and computer readable medium obtaining a network attribute, such as a DNS address, for a short distance wireless network
US20050109981A1 (en) * 2000-06-29 2005-05-26 Tucker Mark D. Decontamination formulations for disinfection and sterilization
US20050222001A1 (en) * 2004-04-05 2005-10-06 Jan Baumeister Stable foamed compositions
US20060018847A1 (en) * 2001-09-25 2006-01-26 Beiersdorf Ag Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
US20060110416A1 (en) * 2004-11-23 2006-05-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Hydroalcoholic cosmetic compositions
US20060198859A1 (en) * 2004-09-25 2006-09-07 Goldschmidt Gmbh Compositions with a depot effect for controlling microorganisms
US20060204468A1 (en) * 2005-03-11 2006-09-14 Goldschmidt Gmbh Cosmetic emulsions with long-term stability
US20060263396A1 (en) * 1995-06-22 2006-11-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US20070065383A1 (en) * 2005-03-07 2007-03-22 Fernandez De Castro Maria T High alcohol content foaming compositions with silicone-based surfactants
US7199090B2 (en) * 2003-09-29 2007-04-03 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant
US20070141007A1 (en) * 2005-12-21 2007-06-21 Glynn John R Jr Novel hair treatment compositions
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
US20080108704A1 (en) * 1997-01-09 2008-05-08 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US20100331422A1 (en) * 1995-06-22 2010-12-30 3M Innovative Properties Company Stable hydroalcoholic compositions

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131152A (en) 1960-06-13 1964-04-28 Allied Chem Foam producing formulations
US3131154A (en) 1961-10-25 1964-04-28 Allied Chem Foam producing compositions
US3824303A (en) 1963-07-24 1974-07-16 Yardley Of London Inc Collapsible foam pre-electric shave lotion containing diester lubricants
US3395214A (en) 1964-01-09 1968-07-30 Scholl Mfg Co Inc Antiperspirant composition providing a readily collapsible sprayable foam
US3709437A (en) 1968-09-23 1973-01-09 Hershel Earl Wright Method and device for producing foam
US3770648A (en) 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
GB1424002A (en) * 1972-05-26 1976-02-04 Unilever Ltd Hair preparations
US3962150A (en) 1974-04-10 1976-06-08 Richardson-Merrell Inc. Foam producing cleansing compositions
US4018364A (en) 1975-04-03 1977-04-19 Hershel Earl Wright Foam dispensing device
US4311695A (en) * 1979-12-03 1982-01-19 Dow Corning Corporation Personal-care emulsions comprising a siloxane-oxyalkylene copolymer
US4511486A (en) 1981-11-02 1985-04-16 Richardson-Vicks Inc. Method of cleaning dentures using aerated foams
US4440653A (en) 1982-03-08 1984-04-03 Halliburton Company Highly stable alcohol foams and methods of forming and using such foams
US4478853A (en) 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
WO1985001876A1 (en) 1983-10-24 1985-05-09 Lockley Services Pty. Ltd. Foamable biocide composition
US4567038A (en) * 1985-03-06 1986-01-28 Revlon, Inc. Sunscreen composition for hair protection
US4826828A (en) * 1985-04-22 1989-05-02 Avon Products, Inc. Composition and method for reducing wrinkles
US4683004A (en) 1985-08-20 1987-07-28 Union Carbide Corporation Foamable compositions and processes for use thereof
US5288486A (en) 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4906459A (en) * 1987-10-23 1990-03-06 The Procter & Gamble Company Hair care compositions
FR2623396B1 (en) * 1987-11-25 1990-03-30 Sanofi Sa USE OF ADEMETIONINE AGAINST AGING SKIN
US4897262A (en) * 1988-03-22 1990-01-30 Playtex Jhirmack, Inc. Non-aerosol hair spray composition
EP0484530B1 (en) 1989-07-28 1995-07-12 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
US5100658A (en) 1989-08-07 1992-03-31 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5290555A (en) * 1989-09-14 1994-03-01 Revlon Consumer Products Corporation Cosmetic compositions with structural color
US4983377A (en) * 1989-10-31 1991-01-08 The Procter & Gamble Company Silicone hairspray compositions
FR2658076B1 (en) * 1990-02-12 1992-06-12 Sanofi Sa COSMETIC COMPOSITION CONTAINING COPOLYMERS OF AMINO ACIDS, USEFUL AS A MOISTURIZING AGENT.
US5128123A (en) 1991-02-08 1992-07-07 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Clear cosmetic sticks
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5284486A (en) * 1991-06-11 1994-02-08 Microvena Corporation Self-centering mechanical medical device
GB9113517D0 (en) * 1991-06-21 1991-08-07 Procter & Gamble Cleansing products
CA2074293C (en) * 1991-07-25 2002-03-19 John R. Horoschak Water-based hair fixative composition
GB9118979D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5494533A (en) 1991-12-12 1996-02-27 Richardson-Vicks, Inc. Method for personal cleansing
US5690921A (en) * 1992-10-15 1997-11-25 Wella Aktiengesellschaft Hair fixing composition in the form of an aqueous solution, foam or gel
JP3398171B2 (en) 1993-03-15 2003-04-21 株式会社資生堂 Oil-in-water emulsion composition
US5635469A (en) 1993-06-10 1997-06-03 The Procter & Gamble Company Foaming cleansing products
US5662893A (en) 1993-06-25 1997-09-02 Eastman Chemical Company Clear pump hair spray formulations containing a linear sulfopolyester in a hydroalcoholic liquid vehicle
US5547662A (en) 1993-08-27 1996-08-20 Becton, Dickinson And Company Preparation of a skin surface for a surgical procedure
FR2709953B1 (en) 1993-09-14 1995-11-24 Oreal Cosmetic composition containing at least one nonionic surfactant of the alkylpolyglycoside and / or polyglycerolated type and at least one polydimethylsiloxane / polyoxalkylene block copolymer.
IT1265001B1 (en) 1993-12-16 1996-10-17 Zambon Spa PHARMACEUTICAL COMPOSITION FOR TOPICAL USE CONTAINING (S) -2- (4- ISOBUTYLPHENYL) PROPIONIC ACID
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US6086856A (en) 1994-03-28 2000-07-11 Oralcare Systems, Inc. System for delivering foamed oral hygiene compositions
US5665332A (en) 1994-03-28 1997-09-09 Oralcare Systems, Inc. System for delivering foams containing medicaments
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
AU4264396A (en) * 1994-11-25 1996-06-19 Laboratoires De Biologie Vegetale Yves Rocher Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
US5856347A (en) * 1994-11-29 1999-01-05 Hisamitsu Pharmaceutical Co., Inc. Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof
FI98290C (en) * 1995-02-08 1997-05-26 Kvaerner Masa Yards Oy Water equalization arrangement
EP2314272A1 (en) 1995-06-22 2011-04-27 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US5612234A (en) * 1995-10-04 1997-03-18 Lg Electronics Inc. Method for manufacturing a thin film transistor
US5733535A (en) * 1995-10-25 1998-03-31 The Procter & Gamble Co. Topical compositions containing N-acetylcysteine and odor masking materials
GB2327881A (en) * 1997-08-06 1999-02-10 Reckitt & Colman Inc Control of dust particles
WO2000006100A1 (en) * 1998-07-30 2000-02-10 The Procter & Gamble Company Hair care product providing shine
US6053369A (en) * 1998-09-28 2000-04-25 Becton Dickinson And Company Foam forming liquid dispensing device
US6262128B1 (en) 1998-12-16 2001-07-17 3M Innovative Properties Company Aqueous foaming compositions, foam compositions, and preparation of foam compositions
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
DE60013098T2 (en) * 1999-02-12 2005-09-01 The Procter & Gamble Company, Cincinnati COMPOSITION FOR SKIN DISINFECTION
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6696053B1 (en) * 2000-05-04 2004-02-24 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Leave-on or rinse-out hair care conditioner compositions containing silicone quaternary compounds and thickeners
US20040191195A1 (en) * 2003-03-28 2004-09-30 Carol Collins Method of promoting a nail composition
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
GB0318160D0 (en) 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
DE102004062775A1 (en) 2004-12-21 2006-06-29 Stockhausen Gmbh Alcoholic pump foam

Patent Citations (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
US4454060A (en) * 1983-06-09 1984-06-12 Colgate-Palmolive Company Liquid detergent composition with a cationic foam stabilizing copolymer containing pendant quaternary nitrogen groups and pendant hydrophobic groups
US4559226A (en) * 1983-09-06 1985-12-17 Bernel Chemical Company Inc. Self-emulsifying alkoxylate esters
US4613592A (en) * 1984-01-09 1986-09-23 Lever Brothers Company Skin treatment composition
US4772592A (en) * 1984-01-09 1988-09-20 Lever Brothers Company Skin treatment composition
US4584189A (en) * 1984-09-28 1986-04-22 Hercules Incorporated Bactericidal toothpastes
US4839166A (en) * 1986-05-16 1989-06-13 L'oreal Cosmestic compositions containing a cationic polymer and an anionic polymer as thickening agent
US4839167A (en) * 1986-09-18 1989-06-13 Kao Corporation Emulsion type hair cosmetic
US4857302A (en) * 1987-02-20 1989-08-15 Decker Jr Donald F Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide
US5232691A (en) * 1989-04-26 1993-08-03 Lemole Gerald M Protective gel composition
US4956170A (en) * 1989-06-28 1990-09-11 S. C. Johnson & Son, Inc. Skin moisturizing/conditioning antimicrobial alcoholic gels
US5104646A (en) * 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5180584A (en) * 1990-01-31 1993-01-19 L'oreal Washing compositions based on insoluble silicones and on a surface-active agent of the polyoxyalkylenated carboxylic ether acid type, and their application in cosmetics and in dermatology
US4986922A (en) * 1990-04-04 1991-01-22 Dow Corning Corporation Softening compositions including quaternary ammonium functional siloxanes
US5980876A (en) * 1991-08-19 1999-11-09 The Procter & Gamble Company Hair spray compositions
US5612324A (en) * 1992-05-05 1997-03-18 The Procter & Gamble Company Method for treating acne
US5362484A (en) * 1992-06-10 1994-11-08 Alberto-Culver Company Hair care composition for conditioning hair with silicone oil
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
US5919439A (en) * 1993-08-23 1999-07-06 The Procter & Gamble Company Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
US5567428A (en) * 1993-08-27 1996-10-22 The Procter & Gamble Company Topical personal care composition containing polysiloxane-grafted adhesive polymer and drying aid
US5626853A (en) * 1994-03-14 1997-05-06 L'oreal Aqueous make-up gel containing organopolysiloxane
US5629006A (en) * 1994-06-27 1997-05-13 Becton, Dickinson And Company Skin disinfecting formulations
US5928993A (en) * 1995-04-28 1999-07-27 Akzo Nobel Nv Aqueous composition, and the use of a wetting-improving agent
US20030211066A1 (en) * 1995-06-22 2003-11-13 3M Innovative Properties Company Stable hydroalcoholic compositions
US20060263396A1 (en) * 1995-06-22 2006-11-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US20100331422A1 (en) * 1995-06-22 2010-12-30 3M Innovative Properties Company Stable hydroalcoholic compositions
US5955408A (en) * 1996-07-10 1999-09-21 Steris Inc. Triclosan skin wash with enhanced efficacy
US5756077A (en) * 1996-09-13 1998-05-26 Avlon Industries, Inc. Hair protectant composition and process for preserving chemically processed hair during subsequent chemical processing
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US20080108704A1 (en) * 1997-01-09 2008-05-08 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US5972356A (en) * 1997-11-05 1999-10-26 The Procter & Gamble Company Personal care compositions
US6333039B1 (en) * 1998-09-25 2001-12-25 Gojo Industries, Inc. Opaque skin sanitizing composition
US6255265B1 (en) * 1998-10-13 2001-07-03 Lever Brothers Company, Division Of Conopco, Inc. Low synthetic soap bars comprising organic salts and polyalkylene glycol
US6497864B1 (en) * 1998-11-26 2002-12-24 L'ORéAL S.A. Hairstyling composition comprising a polymer with particular characteristics and a non-ionic polymer
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US20020028187A1 (en) * 1999-05-07 2002-03-07 Natalia Nekludoff Low voc hair spray compositions having enhanced styling benefits
US20020160924A1 (en) * 1999-06-15 2002-10-31 The Procter & Gamble Company Cleaning compositions
US6524594B1 (en) * 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
US6685952B1 (en) * 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US20020098159A1 (en) * 2000-01-20 2002-07-25 Wei Karl Shiqing Antimicrobial compositions
US6491840B1 (en) * 2000-02-14 2002-12-10 The Procter & Gamble Company Polymer compositions having specified PH for improved dispensing and improved stability of wrinkle reducing compositions and methods of use
US6641825B2 (en) * 2000-03-01 2003-11-04 Henkel Kommanditgesellschaft Auf Aktien Skin cleansing gel having a heating effect
US6638527B2 (en) * 2000-04-17 2003-10-28 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Substantially dry cleansing product of improved latherability and wet flexibility
US6342470B1 (en) * 2000-04-26 2002-01-29 Unilever Home & Personal Care Usa Bar comprising soap, fatty acid, polyalkylene glycol and protic acid salts in critical ratios and providing enhanced skin care benefits
US20020108640A1 (en) * 2000-06-14 2002-08-15 The Procter & Gamble Company Process for cleaning a surface
US6410005B1 (en) * 2000-06-15 2002-06-25 Pmd Holdings Corp. Branched/block copolymers for treatment of keratinous substrates
US20050109981A1 (en) * 2000-06-29 2005-05-26 Tucker Mark D. Decontamination formulations for disinfection and sterilization
US6537952B2 (en) * 2000-08-31 2003-03-25 Unilever Home And Personal Care, Usa Division Of Conopco, Inc. Foaming anti-bacterial cleansing skin product with low water insoluble emollients and foam dispenser
US6617294B2 (en) * 2000-10-20 2003-09-09 Vinod K. Narula Waterless sanitizing hand cleanser
US6472356B2 (en) * 2000-10-20 2002-10-29 Vinod K. Narula Sanitizing hand cleanser comprising an organic alcohol and silicone based materials
US6524494B2 (en) * 2001-02-02 2003-02-25 Givaudan Sa Compositions to enhance fabric freshness and appearance
US20020151446A1 (en) * 2001-02-06 2002-10-17 Playtex Products, Inc. Mild foaming cleanser composition
US20020177535A1 (en) * 2001-02-06 2002-11-28 Playtex Products, Inc. Cleansing compositions with milk protein and aromatherapy
US6730621B2 (en) * 2001-05-14 2004-05-04 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Damp cleansing wipe
US6383997B1 (en) * 2001-07-02 2002-05-07 Dragoco Gerberding & Co. Ag High lathering antibacterial formulation
US20030134761A1 (en) * 2001-07-20 2003-07-17 L'oreal Foaming composition based on silica and on cationic polymer
US20050030917A1 (en) * 2001-08-17 2005-02-10 Amit Haller Device, system, method and computer readable medium obtaining a network attribute, such as a DNS address, for a short distance wireless network
US20060018847A1 (en) * 2001-09-25 2006-01-26 Beiersdorf Ag Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
US20040247685A1 (en) * 2001-10-23 2004-12-09 Shanta Modak Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
US20040001797A1 (en) * 2002-06-21 2004-01-01 Abel Saud Antimicrobial compositions, products and methods employing same
US20030235550A1 (en) * 2002-06-21 2003-12-25 Pan Robert Ya-Lin Antimicrobial compositions, products and methods employing same
US6818603B2 (en) * 2002-08-14 2004-11-16 Johnson & Johnson Consumer Companies, Inc. Cleansing bar containing discrete elements
US20050003990A1 (en) * 2002-11-27 2005-01-06 Smith Kim R. Foam cleaning composition, method for foaming a cleaning composition, and foam dispenser
US20040191274A1 (en) * 2003-03-28 2004-09-30 Grayson Michael L. Topical composition
US7199090B2 (en) * 2003-09-29 2007-04-03 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant
US7683018B2 (en) * 2003-09-29 2010-03-23 Deb Worldwide Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an anionic phosphate fluorosurfactant
US20050222001A1 (en) * 2004-04-05 2005-10-06 Jan Baumeister Stable foamed compositions
US20060198859A1 (en) * 2004-09-25 2006-09-07 Goldschmidt Gmbh Compositions with a depot effect for controlling microorganisms
US20060110416A1 (en) * 2004-11-23 2006-05-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Hydroalcoholic cosmetic compositions
US20070065383A1 (en) * 2005-03-07 2007-03-22 Fernandez De Castro Maria T High alcohol content foaming compositions with silicone-based surfactants
US20070179207A1 (en) * 2005-03-07 2007-08-02 Fernandez De Castro Maria T High alcohol content foaming compositions with silicone-based surfactants
US20070258911A1 (en) * 2005-03-07 2007-11-08 Fernandez De Castro Maria T Method of producing high alcohol content foaming compositions with silicone-based surfactants
US20060204468A1 (en) * 2005-03-11 2006-09-14 Goldschmidt Gmbh Cosmetic emulsions with long-term stability
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US20100327013A1 (en) * 2005-06-13 2010-12-30 3M Innovative Properties Company Foamable alcohol compositions, systems and methods of use
US20100331411A1 (en) * 2005-06-13 2010-12-30 3M Innovative Properties Company Foamable alcohol compositions, systems and methods of use
US20070141007A1 (en) * 2005-12-21 2007-06-21 Glynn John R Jr Novel hair treatment compositions
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803390B2 (en) 1995-06-22 2010-09-28 3M Innovative Properties Company Stable hydroalcoholic compositions
US20100331422A1 (en) * 1995-06-22 2010-12-30 3M Innovative Properties Company Stable hydroalcoholic compositions
US20110110869A1 (en) * 1995-06-22 2011-05-12 3M Innovative Properties Company Stable hydroalcoholic compositions
US20030211066A1 (en) * 1995-06-22 2003-11-13 3M Innovative Properties Company Stable hydroalcoholic compositions
US20080108704A1 (en) * 1997-01-09 2008-05-08 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US8062649B2 (en) 1997-01-09 2011-11-22 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US8569219B2 (en) 2003-09-29 2013-10-29 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions comprising an anionic phosphate fluorosurfactant
US20100160453A1 (en) * 2003-09-29 2010-06-24 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions
US8124115B2 (en) 2004-12-21 2012-02-28 Dep Ip Limited Alcoholic pump foam
US8263098B2 (en) 2005-03-07 2012-09-11 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
US8313758B2 (en) 2005-03-07 2012-11-20 Deb Worldwide Healthcare Inc. Method of producing high alcohol content foaming compositions with silicone-based surfactants
US8309111B2 (en) 2005-03-07 2012-11-13 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
US9414586B2 (en) 2008-07-24 2016-08-16 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9980483B2 (en) 2008-07-24 2018-05-29 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US10499636B2 (en) 2008-07-24 2019-12-10 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9089129B2 (en) 2011-10-07 2015-07-28 American Sterilizer Company Non-aerosol foaming alcohol hand sanitizer
US10799433B2 (en) 2016-04-20 2020-10-13 S. C. Johnson & Son, Inc. Foaming antimicrobial compositions

Also Published As

Publication number Publication date
BRPI0613333A2 (en) 2011-01-04
CA2610945C (en) 2016-06-28
AU2006259687B2 (en) 2012-03-08
TW200710220A (en) 2007-03-16
US7651990B2 (en) 2010-01-26
CN101198308A (en) 2008-06-11
KR20080026546A (en) 2008-03-25
CN101198308B (en) 2013-04-10
US20100331411A1 (en) 2010-12-30
AU2006259687A1 (en) 2006-12-28
JP2008546692A (en) 2008-12-25
WO2006138111A1 (en) 2006-12-28
NO20080261L (en) 2008-03-10
US20060281663A1 (en) 2006-12-14
MX2007015768A (en) 2008-02-15
EP1893167A1 (en) 2008-03-05
JP5266049B2 (en) 2013-08-21
CA2610945A1 (en) 2006-12-28
KR101389199B1 (en) 2014-04-24
US20100327013A1 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
US7651990B2 (en) Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US8679516B2 (en) High alcohol content foaming compositions with silicone-based surfactants
US7670967B2 (en) Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers
KR20000064822A (en) Post-foaming shaving gel containing poly (ethylene oxide) and polyvinylpyrrolidone
US9511006B2 (en) Dispersible moist wipe with emulsion for prevention of skin irritation
US20110287074A1 (en) Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same
JP4815261B2 (en) Wrinkle removal deodorant composition
TW201542235A (en) Skin cleanser composition
US20080311053A1 (en) Fluorinated phosphate ester surfactant and fluorinated alcohol compositions
JP4432345B2 (en) Creamy detergent composition
JP2005509733A (en) Foaming antibacterial preparation
JP2021187834A (en) Aerosol type hair cleanser
JP2022188002A (en) Aqueous cleanser composition

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION